| NCT01256398 | National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | 2010-12-14 | PHASE2 |
| NCT00301782 | Medical Research Council | Extragonadal Germ Cell Tumor|Teratoma|Testicular Germ Cell Tumor | 2005-06 | PHASE2 |
| NCT01249430 | National Cancer Institute (NCI) | Recurrent Adult Acute Myeloid Leukemia|Refractory Acute Myeloid Leukemia | 2011-01-20 | PHASE1 |
| NCT03126916 | Children´s Oncology Group|National Cancer Institute (NCI) | Ganglioneuroblastoma|Ganglioneuroblastoma, Nodular|Neuroblastoma | 2018-05-14 | PHASE3 |
| NCT01228331 | Universit?tsklinikum Hamburg-Eppendorf | Leukemia | 2010-10 | PHASE2|PHASE3 |
| NCT00074178 | OHSU Knight Cancer Institute|National Cancer Institute (NCI) | Lymphoma | 2000-01 | PHASE2 |
| NCT00867178 | National Cancer Institute (NCI) | Medulloblastoma|Pineoblastoma|Supratentorial Embryonal Tumor, Not Otherwise Specified | 2009-02-25 | PHASE1 |
| NCT00293358 | Children´s Cancer and Leukaemia Group | Brain and Central Nervous System Tumors | 1997-01 | PHASE3 |
| NCT02306161 | National Cancer Institute (NCI) | Metastatic Ewing Sarcoma|Metastatic Malignant Neoplasm in the Bone|Metastatic Malignant Neoplasm in the Bone Marrow|Metastatic Malignant Neoplasm in the Lung|Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone|Peripheral Primitive Neuroectodermal Tumor of Soft Tissues | 2014-12-12 | PHASE3 |
| NCT01005758 | Ohio State University Comprehensive Cancer Center|National Cancer Institute (NCI) | Leukemia | 2009-01 | PHASE2 |
| NCT00417053 | Children´s Cancer and Leukaemia Group | Neuroblastoma | | PHASE3 |
| NCT02375204 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|European Organisation for Research and Treatment of Cancer - EORTC|Movember Foundation|Institute of Cancer Research (ICR), United Kingdom|Cancer Research UK|UNICANCER|Irish Group CTI | Germ Cell Tumor|Teratoma|Choriocarcinoma|Germinoma|Mixed Germ Cell Tumor|Yolk Sac Tumor|Childhood Teratoma|Malignant Germ Cell Neoplasm|Extragonadal Seminoma|Non-seminomatous Germ Cell Tumor|Seminoma | 2015-08-06 | PHASE3 |
| NCT03113500 | City of Hope Medical Center|National Cancer Institute (NCI) | Adult T-Cell Leukemia+Lymphoma|Anaplastic Large Cell Lymphoma, ALK-Negative|Anaplastic Large Cell Lymphoma, ALK-Positive|Angioimmunoblastic T-Cell Lymphoma|Ann Arbor Stage II Noncutaneous Anaplastic Large Cell Lymphoma|Ann Arbor Stage III Noncutaneous Anaplastic Large Cell Lymphoma|Ann Arbor Stage IV Noncutaneous Anaplastic Large Cell Lymphoma|Enteropathy-Associated T-Cell Lymphoma|Hepatosplenic T-Cell Lymphoma|Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Peripheral T-Cell Lymphoma, Not Otherwise Specified | 2017-05-25 | PHASE2 |
| NCT01871766 | St. Jude Children´s Research Hospital | Rhabdomyosarcoma | 2013-12-04 | PHASE2 |
| NCT00526318 | German Society for Pediatric Oncology and Hematology GPOH gGmbH | Neuroblastoma | 2007-01 | NA |
| NCT06188676 | National Research Center for Hematology, Russia | Primary Mediastinal Lymphoma | 2022-04-01 | PHASE3 |
| NCT00011921 | EBMT Solid Tumors Working Party | Lung Cancer | 1997-09 | PHASE3 |
| NCT06905509 | Joseph Tuscano|National Cancer Institute (NCI) | Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified|Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements|Recurrent High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements|Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified|Recurrent Nodal Marginal Zone Lymphoma|Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified|Refractory High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements|Refractory High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements|Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified|Refractory Nodal Marginal Zone Lymphoma|Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | 2025-07-31 | PHASE2 |
| NCT00005792 | H. Lee Moffitt Cancer Center and Research Institute|SmithKline Beecham|Bristol-Myers Squibb | Multiple Myeloma|Plasma Cell Neoplasm | 1998-06-02 | PHASE1 |
| NCT00974792 | Cancer Research UK | Lymphoma | 2006-01 | PHASE2 |
| NCT04759586 | National Cancer Institute (NCI) | Primary Mediastinal Large B-Cell Lymphoma | 2021-10-05 | PHASE3 |
| NCT00416819 | University of California, San Francisco|National Cancer Institute (NCI) | Brain and Central Nervous System Tumors|Lymphoma | 2003-09 | NA |
| NCT06942039 | C17 Council | CNS Embryonal Tumor|CNS, Medulloblastoma|Atypical Teratoid Rhabdoid Tumor|Medulloblastoma, Childhood|Medulloblastoma, Group 3|Medulloblastoma, Group 4|Pineoblastoma|Neuroblastoma|Embryonal Tumor With Multilayered Rosettes|Embryonal Tumor With Abundant Neuropil and True Rosettes|Ependymoblastoma|Medulloepithelioma|CNS Embryonal Tumor With Rhabdoid Features|CNS Embryonal Tumor, Nos | 2025-09-23 | EARLY_PHASE1 |
| NCT06356883 | Université de Sherbrooke | Glioblastoma Multiforme|Relapse | 2025-08 | PHASE2 |
| NCT04663347 | Genmab|AbbVie | Diffuse Large B-Cell Lymphoma|Follicular Lymphoma | 2020-11-03 | PHASE1|PHASE2 |
| NCT05092412 | You Lu|AstraZeneca | Lung Cancer|Extensive-stage Small-cell Lung Cancer|Durvalumab | 2022-03-02 | PHASE2 |
| NCT00047281 | Dana-Farber Cancer Institute|National Cancer Institute (NCI)|Schering-Plough|Celgene | Brain and Central Nervous System Tumors | 2004-03 | PHASE2 |
| NCT00092222 | National Cancer Institute (NCI) | Lymphoproliferative Disorder|HHV-8|Malignancy|HIV | 2004-10-28 | PHASE2 |
| NCT00176605 | Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Bristol-Myers Squibb | Prostate Cancer | 2005-05 | PHASE2 |
| NCT02017964 | Children´s Oncology Group|National Cancer Institute (NCI) | Desmoplastic+Nodular Medulloblastoma|Medulloblastoma|Medulloblastoma With Extensive Nodularity|Nevoid Basal Cell Carcinoma Syndrome | 2013-12-24 | PHASE2 |
| NCT00002802 | Children´s Hospital Medical Center, Cincinnati | Neuroblastoma | 1990-07 | PHASE3 |
| NCT03164057 | St. Jude Children´s Research Hospital | Acute Myeloid Leukemia|Myelodysplastic Syndromes | 2017-06-15 | PHASE2 |
| NCT04665856 | Hoffmann-La Roche | Small Cell Lung Carcinoma | 2020-12-21 | PHASE3 |
| NCT01174888 | Alison Walker|Novartis|Millennium Pharmaceuticals, Inc. | Acute Myeloid Leukemia|Acute Myeloid Leukemia With Multilineage Dysplasia Following|Myelodysplastic Syndrome|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Recurrent Adult Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia | 2010-08 | PHASE1 |
| NCT07081022 | Shanghai Junshi Bioscience Co., Ltd. | B-cell Non-Hodgkin´s Lymphoma | 2025-08-17 | PHASE2 |
| NCT07481669 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Lymphoma Patients With High-risk of Central Nervous System Relapse | 2026-03-01 | PHASE2 |
| NCT03125642 | Masonic Cancer Center, University of Minnesota | Non-Hodgkin Lymphoma|Hodgkin Lymphoma | 2017-04-20 | PHASE2 |
| NCT01681537 | Massachusetts General Hospital | Acute Myelogenous Leukemia | 2012-09 | PHASE1 |
| NCT03072771 | Washington University School of Medicine|Amgen | Diffuse Large B Cell Lymphoma | 2017-08-01 | PHASE1 |
| NCT02228512 | National Cancer Institute (NCI) | Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease|Primary Effusion Lymphoma | 2014-08-15 | PHASE1|PHASE2 |
| NCT00578864 | Baylor College of Medicine | Neuroblastoma | 2007-03 | PHASE2 |
| NCT03020030 | Dana-Farber Cancer Institute|Servier | Acute Lymphoblastic Leukemia, Pediatric | 2017-03-03 | PHASE3 |
| NCT00003119 | Children´s Oncology Group|National Cancer Institute (NCI) | Neuroblastoma | 1998-03 | PHASE3 |
| NCT03041311 | G1 Therapeutics, Inc.|Roche-Genentech | Small Cell Lung Cancer | 2017-06-29 | PHASE2 |
| NCT02179528 | Peking University Cancer Hospital & Institute | Small Cell Lung Cancer Extensive Stage | 2014-09 | PHASE2 |
| NCT00039195 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)|Bristol-Myers Squibb|Genentech, Inc. | Lymphoma | 2006-11 | PHASE2 |
| NCT01795430 | City of Hope Medical Center|National Cancer Institute (NCI) | Adult Supratentorial Primitive Neuroectodermal Tumor (PNET)|Ewing Sarcoma of Bone|Extraosseous Ewing Sarcoma|Metastatic Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor|Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor | 2013-07 | NA |
| NCT06086288 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Merkel Cell Carcinoma | 2023-11 | PHASE2 |
| NCT07381829 | HC Biopharma Inc. | Advanced Solid Tumor Cancer | 2025-10-27 | PHASE1 |
| NCT00003727 | University of Maryland, Baltimore|University of Maryland Greenebaum Cancer Center | Leukemia | 1999-03 | PHASE2 |
| NCT01492556 | Chinese Academy of Medical Sciences|Peking University Cancer Hospital & Institute|Peking Union Medical College Hospital|Beijing Chao Yang Hospital|China-Japan Friendship Hospital|Beijing Hospital of the Ministry of Health|The First Affiliated Hospital of Dalian Medical University|The Second Affiliated Hospital of Harbin Medical University|Zhejiang Cancer Hospital|Henan Cancer Hospital|Guangxi Cancer Hospital|Shanghai Putuo District Center Hospital|International Peace Maternity and Child Health Hospital|Xinjiang Medical University | Breast Cancer | 2011-12 | PHASE2 |
| NCT04521946 | M.D. Anderson Cancer Center | Anaplastic Ependymoma|Atypical Teratoid+Rhabdoid Tumor|Central Nervous System Germ Cell Tumor|Choroid Plexus Carcinoma|Intracranial Myeloid Sarcoma|Malignant Brain Neoplasm|Malignant Glioma|Medulloblastoma|Primitive Neuroectodermal Tumor|Recurrent Anaplastic Ependymoma|Recurrent Atypical Teratoid+Rhabdoid Tumor|Recurrent Malignant Brain Neoplasm|Recurrent Malignant Glioma|Recurrent Medulloblastoma|Recurrent Primitive Neuroectodermal Tumor | 2021-01-14 | PHASE1 |
| NCT02402920 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Extensive Stage Small Cell Lung Carcinoma|Limited Stage Small Cell Lung Carcinoma|Neuroendocrine Neoplasm | 2015-07-22 | PHASE1 |
| NCT00002674 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia | 1994-10 | PHASE2 |
| NCT00003190 | National Cancer Institute (NCI) | Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Untreated Adult Acute Myeloid Leukemia | 1998-01 | PHASE3 |
| NCT00276718 | Children´s Cancer and Leukaemia Group | Brain and Central Nervous System Tumors|Childhood Germ Cell Tumor|Extragonadal Germ Cell Tumor|Ovarian Cancer | 1989-04 | NA |
| NCT01013779 | Trans Tasman Radiation Oncology Group | Merkel Cell Carcinoma | 2009-12 | PHASE2 |
| NCT00774046 | University of Chicago | Myelodysplastic Syndrome|Acute Myeloid Leukemia | 2002-12 | PHASE2 |
| NCT05364424 | Hoffmann-La Roche | Diffuse Large B-Cell Lymphoma (DLBCL) | 2022-11-04 | PHASE1 |
| NCT05389423 | National Cancer Institute (NCI) | Diffuse Large Cell Lymphoma|Non-Hodgkin Lymphoma|Burkitt Lymphoma|Plasmablastic Lymphoma|B-Cell Neoplasm | 2023-06-27 | PHASE1 |
| NCT00598169 | AIDS Malignancy Consortium|National Cancer Institute (NCI)|The Emmes Company, LLC | Lymphoma | 2007-11 | PHASE1 |
| NCT00002766 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Leukemia|Lymphoma | 1996-03 | PHASE3 |
| NCT02101853 | National Cancer Institute (NCI) | Recurrent B Acute Lymphoblastic Leukemia | 2014-12-17 | PHASE3 |
| NCT01859741 | OncoMed Pharmaceuticals, Inc. | Stage IV Small Cell Lung Cancer | 2012-01-07 | PHASE1|PHASE2 |
| NCT06563245 | Children´s Cancer Group, China|Shanghai Children´s Medical Center|Najing Children´s Hospital|West China Second University Hospital|Qilu Hospital of Shandong University|Tianjin Medical University Cancer Institute and Hospital|Tongji Hospital|Xiangya Hospital of Central South University|The First Affiliated Hospital of Zhengzhou University|The Second Hospital of Anhui Medical University|Children´s Hospital of Hebei Province|Children´s Hospital of Henan Province|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Classical Hodgkin Lymphoma|Child|Adolescent|Young Adult|Metabolic Response|Survival|Treatment|Brentuximab Vedotin|PET Scan | 2024-09-25 | PHASE2|PHASE3 |
| NCT00602771 | National Cancer Institute (NCI) | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Secondary Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia | 2008-01 | PHASE2 |
| NCT00002521 | Temple University | Lymphoma | 1993-02 | PHASE2 |
| NCT05491304 | The Children´s Hospital of Zhejiang University School of Medicine|The Second Hospital of Anhui Medical University|Union hospital of Fujian Medical University|Children´s Hospital of Fudan University|Zunyi Medical College|Hunan Provincial People´s Hospital|Tongji Hospital|Children´s Hospital of Nanjing Medical University|The Affiliated Hospital of Qingdao University|Qilu Hospital of Shandong University|Shanghai Children´s Medical Center|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|Shanghai Children´s Hospital|Shenzhen Children´s Hospital|West China Second University Hospital|Children´s Hospital of Soochow University|Second Affiliated Hospital of Wenzhou Medical University|Wuhan Children´s Hospital|Institute of Hematology & Blood Diseases Hospital, China|The Third Xiangya Hospital of Central South University|First Affiliated Hospital, Sun Yat-Sen University | Hemophagocytic Lymphohistiocytoses|Cytokine Storm | 2022-09-01 | PHASE4 |
| NCT01920932 | St. Jude Children´s Research Hospital|Seagen Inc. | Stage II Childhood Hodgkin Lymphoma|Stage III Childhood Hodgkin Lymphoma|Stage IV Childhood Hodgkin Lymphoma | 2013-08-12 | PHASE2 |
| NCT02512926 | Stanford University|The Pediatric Oncology Experimental Therapeutics Investigators´ Consortium|Amgen | Relapsed Solid Tumors|Refractory Solid Tumors|Relapsed Leukemia|Refractory Leukemia | 2016-02-16 | PHASE1 |
| NCT00006126 | Northwestern University|National Cancer Institute (NCI) | Breast Cancer|Kidney Cancer|Lung Cancer|Melanoma (Skin)|Testicular Germ Cell Tumor | 1999-09 | PHASE1 |
| NCT00562978 | City of Hope Medical Center|National Cancer Institute (NCI) | Lymphoma | 2000-05-16 | PHASE1|PHASE2 |
| NCT00616785 | Yonsei University | Lung Cancer | 2007-06 | PHASE2 |
| NCT05681260 | Children´s Cancer Group, China|Shanghai Children´s Medical Center|Beijing Children´s Hospital|Children´s Hospital of Scow University|West China Second University Hospital|Nanjing Children´s Hospital|Qilu Hospital of Shandong University|Tianjin Medical University Cancer Institute and Hospital|Tongji Hospital|Xiangya Hospital of Central South University|The First Affiliated Hospital of Zhengzhou University|Cancer hospital of Shandong Province|Shenzhen Children´s Hospital|Wuhan Children´s Hospital|The Children´s Hospital of Zhejiang University School of Medicine|Shanghai Children´s Hospital|Ruijin Hospital|The Second Hospital of Anhui Medical University|Children´s Hospital of Hebei Province|Cancer Hospital of Henan Province|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|Qilu Children´s Hospital | T-cell Lymphoblastic Lymphoma | 2023-02-06 | PHASE3 |
| NCT00005090 | SWOG Cancer Research Network|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|Cancer and Leukemia Group B | Lymphoma | 2000-04 | PHASE3 |
| NCT03553238 | Nanfang Hospital, Southern Medical University | Leukemia, Acute|Leukemia, T Cell|Leukemia, Lymphoblastic | 2016-02-14 | PHASE2|PHASE3 |
| NCT00417248 | Nasser Hanna, M.D.|Bayer|Amgen|Walther Cancer Institute | Non-Small Cell Lung Cancer | 2007-06 | PHASE1|PHASE2 |
| NCT01451515 | St. Jude Children´s Research Hospital|National University of Singapore | Lymphoblastic Lymphoma | 2012-05-25 | PHASE2 |
| NCT00186849 | St. Jude Children´s Research Hospital|National Institutes of Health (NIH) | Neuroblastoma | 1997-10 | PHASE2 |
| NCT02738346 | University Hospital, Angers | Small Cell Lung Cancer | 2013-07 | PHASE3 |
| NCT00003860 | UNICANCER | Lung Cancer | 1998-09 | PHASE2 |
| NCT00006258 | Children´s Hospital Los Angeles|National Cancer Institute (NCI) | Brain and Central Nervous System Tumors | 1997-11 | PHASE2 |
| NCT00499343 | M.D. Anderson Cancer Center|Bayer | Lymphoma | 2004-01 | PHASE2 |
| NCT04981899 | St. Petersburg State Pavlov Medical University | Hodgkin Lymphoma | 2021-03-01 | PHASE1|PHASE2 |
| NCT00193505 | SCRI Development Innovations, LLC|Biogen | Non-Hodgkins Lymphoma | 2003-10 | PHASE2 |
| NCT00006032 | H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI) | Breast Cancer | 2000-03 | PHASE2 |
| NCT00039130 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Leukemia|Lymphoma | 2002-05 | PHASE2 |
| NCT06648200 | Shanghai Pulmonary Hospital, Shanghai, China | Small Cell Lung Cancer Extensive Stage|Small Cell Lung Cancer Recurrent | 2024-11-01 | PHASE2 |
| NCT02161692 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Testicular Neoplasms|Germ Cell Tumors | 1996-12 | PHASE2 |
| NCT02987244 | Peking Union Medical College Hospital|Chinese PLA General Hospital|Peking University First Hospital|Peking University Third Hospital|Peking University Cancer Hospital & Institute|Tianjin Medical University Cancer Institute and Hospital | T Cell Non-Hodgkin´s Lymphoma | 2016-03 | PHASE1|PHASE2 |
| NCT06741644 | CStone Pharmaceuticals | Advanced Solid Tumors | 2025-02-24 | PHASE1|PHASE2 |
| NCT02243436 | Grupo Espa?ol de Linfomas y Transplante Autólogo de Médula ósea|Millennium Pharmaceuticals, Inc. | CLASSICAL HODGKIN LYMPHOMA | 2014-11-11 | PHASE1|PHASE2 |
| NCT00004899 | Northwestern University|National Cancer Institute (NCI) | Leukemia|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 1999-10 | PHASE2 |
| NCT02219737 | National Cancer Institute (NCI) | CD20 Positive|Recurrent Diffuse Large B-Cell Lymphoma|Refractory Diffuse Large B-Cell Lymphoma | 2014-09-12 | PHASE1 |
| NCT00057837 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) | Extensive Stage Small Cell Lung Cancer | 2004-07-14 | PHASE2 |
| NCT00264953 | University of Cologne | Hodgkin?s Lymphoma | 1998-05 | PHASE3 |
| NCT01857453 | Central Hospital, Nancy, France|University Hospital, Bordeaux|Centre Paul Strauss|Centre Hospitalier Universitaire de Nice|CRLCC Val d´Aurelle, Montpellier|Centre Georges Francois Leclerc|Gustave Roussy, Cancer Campus, Grand Paris|Centre Leon Berard|Groupe Hospitalier Pitie-Salpetriere|H?pital de la Timone|CHU de Reims|Hopitaux Civils de Colmar|University Hospital, Lille|Institut Claudius Regaud|Centre Francois Baclesse|Center Eugene Marquis|Centre René Gauducheau|Centre Hospitalier Universitaire, Amiens | Medulloblastoma | 2013-04-10 | PHASE2 |
| NCT05535166 | St. Jude Children´s Research Hospital|National Cancer Institute (NCI) | Medulloblastoma | 2022-12-20 | PHASE2 |
| NCT06954805 | Jennifer Amengual|The Leukemia and Lymphoma Society | Lymphoma|Lymphoma, B-Cell | 2025-04-14 | PHASE2 |
| NCT03467256 | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | B-cell Acute Lymphoblastic Leukemia|Acute Lymphocytic Leukemia, Pediatric | 2018-05-14 | PHASE1|PHASE2 |
| NCT05309629 | Qilu Pharmaceutical Co., Ltd. | Extensive-stage Small-cell Lung Cancer | 2022-04-18 | PHASE2 |
| NCT03628131 | Samsung Medical Center|Ministry of Health, Republic of Korea | Relapsed Pediatric Solid Tumor|Refractory Pediatric Solid Tumor | 2018-10 | PHASE1|PHASE2 |
| NCT06110572 | Vanderbilt-Ingram Cancer Center|Genentech, Inc. | Extensive Stage Lung Small Cell Carcinoma|Stage IV Lung Cancer | 2024-04-24 | PHASE1|PHASE2 |
| NCT01579929 | Memorial Sloan Kettering Cancer Center|Novartis Pharmaceuticals | Lung Cancer | 2012-04 | PHASE1 |
| NCT04871607 | City of Hope Medical Center|National Cancer Institute (NCI) | Recurrent Hodgkin Lymphoma|Refractory Hodgkin Lymphoma | 2021-11-02 | PHASE2 |
| NCT00003935 | Children´s Oncology Group|National Cancer Institute (NCI) | Brain Tumors|Central Nervous System Tumors | 1999-09 | PHASE1 |
| NCT05572476 | Institut Bergonié|AstraZeneca|PharmaMar | Small Cell Lung Cancer|Platinum-Sensitive Lung Small Cell Carcinoma|Extensive-stage Small-cell Lung Cancer | 2023-10 | PHASE2 |
| NCT00003650 | UNICANCER | Lymphoma | 1997-02 | PHASE3 |
| NCT00006260 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) | Breast Cancer | 1997-05 | PHASE2 |
| NCT03071822 | The University of Hong Kong | Peripheral T Cell Lymphoma | 2017-02-24 | PHASE4 |
| NCT04803201 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Angioimmunoblastic T-cell Lymphoma|Enteropathy-Associated T-Cell Lymphoma|Follicular T-Cell Lymphoma|Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma|Nodal Peripheral T-Cell Lymphoma With TFH Phenotype|Peripheral T-Cell Lymphoma, Not Otherwise Specified | 2021-10-08 | PHASE2 |
| NCT06528496 | Memorial Sloan Kettering Cancer Center | High-risk Neuroblastoma|Neuroblastoma|Childhood Neuroblastoma | 2024-07-22 | PHASE2 |
| NCT00072527 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Lung Cancer | 2003-11 | PHASE2 |
| NCT00002566 | UNICANCER | Extragonadal Germ Cell Tumor|Testicular Germ Cell Tumor | 1994-02 | PHASE3 |
| NCT00003423 | United Kingdom Children´s Cancer Study Group | Lymphoma | 1995-05 | PHASE3 |
| NCT02845882 | Children´s Cancer Group, China|Shanghai Children´s Medical Center|Tongji Hospital|West China Second University Hospital|Qilu Hospital of Shandong University|Tianjin Medical University Cancer Institute and Hospital|Children´s Hospital of Soochow University|Nanjing Children´s Hospital|Xiangya Hospital of Central South University | Lymphoblastic Lymphoma | 2016-01 | PHASE3 |
| NCT04154189 | Eisai Inc.|Merck Sharp & Dohme LLC | Osteosarcoma | 2020-03-23 | PHASE2 |
| NCT00401609 | National Cancer Institute, Naples | Small Cell Lung Cancer | 2000-11 | PHASE1|PHASE2 |
| NCT04254471 | Haihe Biopharma Co., Ltd. | Extensive-stage Small Cell Lung Cancer | 2019-11-14 | PHASE2|PHASE3 |
| NCT00003421 | Medical Research Council | Lymphoma | 1998-06 | PHASE3 |
| NCT02905110 | The University of Texas Health Science Center, Houston | Brain Tumor Recurrent | 2017-10-12 | EARLY_PHASE1 |
| NCT00003625 | Children´s Oncology Group|National Cancer Institute (NCI) | Brain Tumors|Central Nervous System Tumors | 1998-12 | PHASE1 |
| NCT00381680 | Children´s Oncology Group|National Cancer Institute (NCI) | B-cell Childhood Acute Lymphoblastic Leukemia|L1 Childhood Acute Lymphoblastic Leukemia|L2 Childhood Acute Lymphoblastic Leukemia|Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia | 2007-03 | PHASE3 |
| NCT00003380 | Gynecologic Oncology Group|National Cancer Institute (NCI) | Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer | 1998-05 | PHASE1 |
| NCT00006373 | H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI) | Lymphoma | 2000-02 | PHASE2 |
| NCT06756152 | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Biphenotypic Acute Leukemia|Acute Lymphoblastic Leukemia|Myeloblastic Leukemia|Bilinear Leukemia|Malignant Lymphoma, Non-Hodgkin|Myelodysplastic Syndrome | 2024-07-10 | PHASE2|PHASE3 |
| NCT00007852 | University of Nebraska|National Cancer Institute (NCI)|Genentech, Inc. | Lymphoma | 2000-09-01 | PHASE2 |
| NCT05228249 | Fred Hutchinson Cancer Center|ADC Therapeutics | Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified|Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements|Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma|Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified|Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements|Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma|Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | 2023-04 | PHASE1 |
| NCT00792948 | National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Adult L1 Acute Lymphoblastic Leukemia|Adult L2 Acute Lymphoblastic Leukemia|Adult T Acute Lymphoblastic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia | 2009-09-01 | PHASE2 |
| NCT01904643 | Stanford University|National Cancer Institute (NCI) | Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Recurrent Adult Acute Myeloid Leukemia | 2014-02 | PHASE1 |
| NCT00020566 | University of Leicester|National Cancer Institute (NCI)|Children´s Cancer and Leukaemia Group|Societe Francaise Oncologie Pediatrique|European Organisation for Research and Treatment of Cancer - EORTC|German Society for Pediatric Oncology and Hematology GPOH gGmbH|Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria|Swiss Cancer Institute|EBMT Solid Tumors Working Party|Children´s Oncology Group | Sarcoma | 2001-02 | PHASE3 |
| NCT06049966 | Oncology Center of Biochemical Education And Research | Large Cell Neuroendocrine Carcinoma of the Lung | 2018-03-01 | PHASE1 |
| NCT05338541 | Yizhuo Zhang | Neuroblastoma in Children | 2022-05-27 | PHASE1 |
| NCT01458366 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University|GlaxoSmithKline|Novartis | Non-Hodgkin´s Lymphoma | 2011-11-09 | PHASE1|PHASE2 |
| NCT04049669 | Theodore S. Johnson|National Cancer Institute (NCI)|Augusta University|Emory University | Glioblastoma|Medulloblastoma|Ependymoma|Diffuse Intrinsic Pontine Glioma | 2019-10-02 | PHASE2 |
| NCT00627354 | Groupe D´Etude des Tumeurs Uro-Genitales | Prostate Cancer | 2006-09 | PHASE2 |
| NCT07245446 | Akeso | Extensive-stage Small Cell Lung Cancer (ES-SCLC) | 2025-10-29 | PHASE2 |
| NCT00003859 | Societe Internationale d´Oncologie Pediatrique | Brain and Central Nervous System Tumors | 1992-04 | PHASE3 |
| NCT02561273 | University of Nebraska|National Cancer Institute (NCI) | Anaplastic Large Cell Lymphoma, ALK-Negative|Anaplastic Large Cell Lymphoma, ALK-Positive|Hepatosplenic T-Cell Lymphoma|Peripheral T-Cell Lymphoma, Not Otherwise Specified|Stage II Angioimmunoblastic T-cell Lymphoma|Stage II Enteropathy-Associated T-Cell Lymphoma|Stage III Angioimmunoblastic T-cell Lymphoma|Stage III Enteropathy-Associated T-Cell Lymphoma|Stage IV Angioimmunoblastic T-cell Lymphoma|Stage IV Enteropathy-Associated T-Cell Lymphoma | 2015-09-28 | PHASE1|PHASE2 |
| NCT06401330 | Children´s Oncology Group | Stage I Mixed Cell Type Kidney Wilms Tumor|Stage II Mixed Cell Type Kidney Wilms Tumor|Stage III Mixed Cell Type Kidney Wilms Tumor|Stage IV Mixed Cell Type Kidney Wilms Tumor | 2025-04-15 | PHASE3 |
| NCT07538271 | Yayi He|Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | SCLC, Extensive Stage | 2026-04-20 | PHASE2 |
| NCT04765098 | AHS Cancer Control Alberta | Glioblastoma Multiforme | 2022-01-28 | PHASE2 |
| NCT00004128 | European Organisation for Research and Treatment of Cancer - EORTC|Gruppo Italiano Malattie EMatologiche dell´Adulto | Leukemia | 1999-09 | PHASE3 |
| NCT02043587 | University of California, San Diego|Leadiant Biosciences, Inc. | Acute Lymphocytic Leukemia|Adult Lymphoblastic Lymphoma | 2014-01 | PHASE2 |
| NCT00003852 | UNICANCER | Childhood Germ Cell Tumor|Extragonadal Germ Cell Tumor|Ovarian Cancer|Testicular Germ Cell Tumor | 1998-03 | PHASE2 |
| NCT00432094 | Masonic Cancer Center, University of Minnesota | Childhood Germ Cell Tumor|Ovarian Cancer|Teratoma | 2006-12-19 | PHASE2 |
| NCT01134861 | Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology | Lung Cancer | 1994-07 | PHASE3 |
| NCT01589159 | Tao OUYANG | Metastatic Breast Cancer | 2013-01 | PHASE2 |
| NCT03504410 | Cornerstone Pharmaceuticals | Relapsed+Refractory Acute Myeloid Leukemia | 2018-11-12 | PHASE3 |
| NCT00573690 | UNC Lineberger Comprehensive Cancer Center|National Cancer Institute (NCI) | Unspecified Adult Solid Tumor, Protocol Specific | 2007-09 | PHASE1 |
| NCT04501718 | Beijing Sanbo Brain Hospital | Recurrent Medulloblastoma | 2020-10-28 | PHASE2 |
| NCT00544115 | City of Hope Medical Center|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases|Precancerous+Nonmalignant Condition | 2001-10-16 | PHASE2 |
| NCT00003389 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) | Lymphoma | 1999-06-17 | PHASE3 |
| NCT00005823 | Leukemia Research Fund | Leukemia|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 1998-12 | PHASE3 |
| NCT00400946 | Dana-Farber Cancer Institute|National Cancer Institute (NCI) | Drug+Agent Toxicity by Tissue+Organ|Leukemia | 2005-04 | PHASE3 |
| NCT02359162 | Sun Yat-sen University | Lymphoma, Extranodal NK-T-Cell | 2015-05 | PHASE3 |
| NCT04077905 | Beijing Friendship Hospital | Hemophagocytic Lymphohistiocytosis | 2019-08-31 | PHASE3 |
| NCT00716066 | Fred Hutchinson Cancer Center | Autoimmune Disease|Neurologic Autoimmune Disease|Autologous Transplant Autoimmune|Multiple Sclerosis Transplant|MS Stem Cell Transplant|Multiple Sclerosis Stem Cell Transplant|Stiff Person Syndrome|HCT for Neurologic Autoimmune Disorders|CIDP Transplant|Myasthenia Gravis Transplant|Autoimmune Nervous System Disorder|Central Nervous System Vasculitis|Cerebellar Degeneration|Chronic Inflammatory Demyelinating Polyneuropathy|Lambert Eaton Myasthenic Syndrome|Myasthenia Gravis|Neuromyelitis Optica|Opsoclonus Myoclonus Syndrome|Rasmussen Subacute Encephalitis | 2008-06 | PHASE2 |
| NCT02797470 | AIDS Malignancy Consortium|National Cancer Institute (NCI)|California Institute for Regenerative Medicine (CIRM) | HIV Infection|Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Plasmablastic Lymphoma|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Non-Hodgkin Lymphoma|Recurrent Burkitt Lymphoma|Recurrent Follicular Lymphoma|Stage III Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage IV Follicular Lymphoma|Stage IV Mantle Cell Lymphoma | 2016-06-23 | PHASE1|PHASE2 |
| NCT05270057 | Medical College of Wisconsin | B-cell Lymphoma|Burkitt Lymphoma | 2023-01-26 | PHASE1 |
| NCT00002003 | Lederle Laboratories | Lymphoma, Non-Hodgkin|HIV Infections | | PHASE2 |
| NCT06830694 | Se-Hoon Lee | Small Cell Carcinoma of Lung | 2025-05-13 | PHASE2 |
| NCT00822120 | SWOG Cancer Research Network|National Cancer Institute (NCI) | Lymphoma|Nonneoplastic Condition | 2009-07 | PHASE2 |
| NCT01076231 | Abramson Cancer Center at Penn Medicine | Stage IIIA Non-small Cell Lung Cancer | 2010-01 | PHASE1|PHASE2 |
| NCT06937866 | Indiana University|Exelixis | Germ Cell Tumor | 2025-11-12 | PHASE1|PHASE2 |
| NCT00003602 | Riverside Haematology Group | Leukemia|Myelodysplastic Syndromes | 1998-03 | PHASE3 |
| NCT05913427 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Adrenocortical Carcinoma | 2022-06-08 | PHASE2 |
| NCT04778410 | Gilead Sciences | Myeloid Malignancies | 2021-06-28 | PHASE2 |
| NCT03023046 | University of Washington|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma | 2017-02-23 | PHASE2 |
| NCT01468740 | Harlachinger Krebshilfe e.V.|Deutsche AIDS Gesellschaft e.V. | HIV-associated Hodgkin Lymphoma | 2004-03 | PHASE2 |
| NCT05624996 | NRG Oncology | Locally Advanced Lung Non-Small Cell Carcinoma|Stage IIB Lung Cancer AJCC v8|Stage III Lung Cancer AJCC v8 | 2023-07-12 | PHASE3 |
| NCT00107354 | Fred Hutchinson Cancer Center | Leukemia|Myelodysplastic Syndromes | 1998-12 | PHASE1 |
| NCT04774380 | AstraZeneca | Extensive-stage Small Cell Lung Cancer | 2021-11-11 | PHASE3 |
| NCT05566041 | EpicentRx, Inc.|Sciclone Pharmaceuticals (China) Co., Ltd. | Carcinoma, Small Cell Lung | 2022-08-01 | PHASE3 |
| NCT00002489 | Memorial Sloan Kettering Cancer Center | Extragonadal Germ Cell Tumor|Ovarian Cancer | 1991-10 | PHASE2 |
| NCT02595424 | ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI) | Gastric Neuroendocrine Carcinoma|Intestinal Neuroendocrine Carcinoma|Pancreatic Neuroendocrine Carcinoma | 2015-11-06 | PHASE2 |
| NCT06418594 | Beijing 302 Hospital | HER2-negative Breast Cancer Brain Metastases | 2024-10-10 | PHASE2 |
| NCT01197560 | Celgene | Diffuse Large B-cell Lymphoma | 2010-09-02 | PHASE2|PHASE3 |
| NCT00204646 | University Hospital Tuebingen | Sarcoma, Soft Tissue | 1999-02 | PHASE2 |
| NCT00003631 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Lymphoma | 1998-08 | PHASE2 |
| NCT02636322 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Diffuse Large B-Cell Lymphoma Unclassifiable | 2016-03-29 | PHASE2 |
| NCT04189094 | Zhejiang Cancer Hospital|First Affiliated Hospital, Sun Yat-Sen University|Affiliated Hospital of Guangdong Medical University|First People´s Hospital of Foshan | Small Cell Lung Cancer Limited Stage | 2020-01-01 | PHASE2 |
| NCT07544654 | Boehringer Ingelheim | Extrapulmonary Neuroendocrine Cancer | 2026-06-15 | PHASE3 |
| NCT05058651 | National Cancer Institute (NCI) | Advanced Extrapulmonary Neuroendocrine Carcinoma|Metastatic Extrapulmonary Neuroendocrine Carcinoma|Recurrent Extrapulmonary Neuroendocrine Carcinoma|Unresectable Extrapulmonary Neuroendocrine Carcinoma | 2022-06-28 | PHASE2|PHASE3 |
| NCT00002822 | Medical Research Council | Lung Cancer | 1996-03 | PHASE3 |
| NCT02059239 | Weill Medical College of Cornell University | Hodgkin´s Lymphoma|Non-Hodgkin´s Lymphoma | 2014-06-04 | PHASE1|PHASE2 |
| NCT02574728 | Emory University|Cannonball Kids´ Cancer Foundation|Hyundai Hope On Wheels | Cancer | 2015-06 | PHASE2 |
| NCT03515707 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Acute Myeloid Leukemia|Minimal Residual Disease Negativity | 2018-07-10 | PHASE2 |
| NCT00660036 | University of Pittsburgh | Acute Myeloid Leukemia | 2008-09 | PHASE1 |
| NCT00826644 | Chonnam National University Hospital|Chong Kun Dang Pharmaceutical | Carcinoma, Small Cell | 2009-01 | PHASE3 |
| NCT00539500 | M.D. Anderson Cancer Center | Neuroblastoma | 2007-10 | PHASE2|PHASE3 |
| NCT01059071 | Giselle Sholler|Cancer Prevention Pharmaceuticals, Inc.|University of Arizona|University of Hawaii | Neuroblastoma | 2010-02 | PHASE1 |
| NCT07117877 | Fudan University | Platinum Resistant Ovarian Cancer|Platinum Refractory Epithelial Ovarian Cancer|Ovarian Cancer (OvCa) | 2025-09-15 | PHASE2 |
| NCT07224100 | University of Washington|Takeda | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|B Lymphoblastic Leukemia+Lymphoma With t(9;22)(q34.1;q11.2); BCR-ABL1|Lymphoblastic Lymphoma | 2026-03-30 | PHASE2 |
| NCT05784987 | The First Affiliated Hospital with Nanjing Medical University | Diffuse Large B-cell Lymphoma | 2023-04-15 | NA |
| NCT00002657 | SWOG Cancer Research Network|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group | Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm | 1995-05 | PHASE2 |
| NCT01411098 | University of Washington|National Cancer Institute (NCI) | Recurrent Non-small Cell Lung Cancer|Stage IIB Non-small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer | 2011-10 | PHASE1 |
| NCT01756989 | Helsinki University Central Hospital|Kuopio University Hospital|Oulu University Hospital|Tampere University Hospital|Turku University Hospital | Brainstem Glioma | 2005-01 | PHASE2 |
| NCT00003052 | European Organisation for Research and Treatment of Cancer - EORTC|The European Society for Hyperthermic Oncology | Sarcoma | 1997-07 | PHASE3 |
| NCT07361133 | National Cancer Institute, Egypt | Squamous Cell Carcinoma|Advanced Head and Neck Cancer | 2026-04 | PHASE2 |
| NCT00695409 | City of Hope Medical Center|National Cancer Institute (NCI) | Lymphoma | 2008-03-18 | PHASE2 |
| NCT03707847 | Mingzhi Zhang | ALK-Positive Anaplastic Large Cell Lymphoma | 2018-10-01 | PHASE4 |
| NCT00363415 | Eli Lilly and Company | Small Cell Lung Cancer | 2006-08 | PHASE3 |
| NCT02899728 | National Cancer Institute (NCI) | Extensive Stage Lung Small Cell Carcinoma | 2018-03-30 | PHASE2 |
| NCT00537511 | Celgene | Carcinoma, Small Cell | 2008-02-01 | PHASE1|PHASE2 |
| NCT07373964 | China Medical University, China | Small Cell Lung Cancer | 2025-10-15 | PHASE2 |
| NCT00004898 | Northwestern University|National Cancer Institute (NCI) | Leukemia|Lymphoma | 1999-10 | PHASE1|PHASE2 |
| NCT02825147 | Ruijin Hospital | Nasal Type Extranodal NK+T-Cell Lymphoma | 2013-09 | PHASE2 |
| NCT03742115 | Beijing Friendship Hospital | Hemophagocytic Lymphohistiocytosis | 2018-12-01 | PHASE3 |
| NCT02583893 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Recurrent Adult Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia | 2015-10-07 | PHASE2 |
| NCT00002836 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Breast Cancer | 1995-09-26 | PHASE3 |
| NCT00003816 | Roswell Park Cancer Institute | Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases|Nonmalignant Neoplasm|Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol Specific | 1998-10-19 | PHASE2|PHASE3 |
| NCT03036904 | Weill Medical College of Cornell University|Genentech, Inc.|Massachusetts General Hospital|M.D. Anderson Cancer Center | Diffuse Large B-Cell Lymphoma|High Grade B-Cell Lymphoma | 2017-02-06 | PHASE1 |
| NCT01110135 | University of Washington|National Cancer Institute (NCI) | Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Peripheral T-cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Refractory Multiple Myeloma|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Waldenstr?m Macroglobulinemia | 2010-08 | PHASE2 |
| NCT00104676 | UNICANCER | Extragonadal Germ Cell Tumor|Teratoma|Testicular Germ Cell Tumor | 2003-11-26 | PHASE3 |
| NCT03613597 | Guizhou Medical University | Small-cell Lung Cancer | 2018-06-01 | PHASE2 |
| NCT05546060 | Beijing Friendship Hospital | Hemophagocytic Lymphohistiocytosis | 2022-07-01 | PHASE1 |
| NCT00002982 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Lymphoma | 1997-01 | PHASE2 |
| NCT04256421 | Hoffmann-La Roche | Small Cell Lung Cancer | 2020-02-04 | PHASE3 |
| NCT00515138 | University of California, San Francisco | Lymphoma, B-Cell | 2007-05 | EARLY_PHASE1 |
| NCT01947062 | Swami Rama Cancer Hospital and Research Institute | Lung Cancer|Squamous Cell Carcinoma of the Lung|Locally Advanced and Metastatic Squamous Cell Carcinoma of the Lung | 2013-10 | PHASE3 |
| NCT07258680 | N.N. Petrov National Medical Research Center of Oncology | Peripheral T-cell Lymphoma | 2013-10 | PHASE3 |
| NCT00002785 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 1996-07 | PHASE2 |
| NCT00002610 | Children´s Oncology Group|National Cancer Institute (NCI) | Kidney Cancer | 1996-01 | PHASE3 |
| NCT00871013 | University of Arkansas | Myeloma | 2009-03 | PHASE2 |
| NCT05106296 | Theodore S. Johnson|Augusta University|CureSearch for Children´s Cancer|Rally Foundation for Childhood Cancer Research | Ependymoma|Medulloblastoma|Glioblastoma|Primary Brain Tumor | 2022-02-08 | PHASE1 |
| NCT06897579 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Extensive Stage Small Cell Lung Cancer | 2025-04-07 | PHASE2 |
| NCT02504359 | OHSU Knight Cancer Institute|Oregon Health and Science University | Plasma Cell Leukemia|Recurrent Plasma Cell Myeloma | 2015-07-20 | PHASE1 |
| NCT00274950 | Children´s Cancer and Leukaemia Group | Childhood Germ Cell Tumor|Extragonadal Germ Cell Tumor|Ovarian Cancer | 2005-05 | PHASE3 |
| NCT00070174 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 2003-12 | PHASE2 |
| NCT01258634 | University of Chicago | Osteosarcoma|Lung Metastases | 2010-07 | PHASE1 |
| NCT01390584 | ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI) | Lymphoma | 2013-05-24 | PHASE2 |
| NCT07097363 | University of Washington|AbbVie | B-Cell Non-Hodgkin Lymphoma|Burkitt Lymphoma|Diffuse Large B-Cell Lymphoma, Not Otherwise Specified|EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified|High Grade B-Cell Lymphoma With MYC and BCL2 and+or BCL6 Rearrangements|High Grade B-Cell Lymphoma, Not Otherwise Specified|Primary Mediastinal Large B-Cell Lymphoma|T-Cell+Histiocyte-Rich Large B-Cell Lymphoma|Transformed B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma to Diffuse Large B-Ce | 2025-12-07 | PHASE2 |
| NCT00589563 | City of Hope Medical Center|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Infection|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms|Precancerous Condition|Secondary Myelofibrosis|Small Intestine Cancer | 2007-05 | PHASE2 |
| NCT00002714 | Stanford University|National Cancer Institute (NCI) | Lymphoma | 1995-04 | PHASE2 |
| NCT04472949 | Swiss Cancer Institute | Small Cell Lung Cancer|Lung Cancer | 2021-06-25 | PHASE2 |
| NCT05510089 | The Affiliated People´s Hospital of Ningbo University | Hematological Malignancy | 2022-09-01 | NA |
| NCT00003269 | Scripps Health | Breast Cancer|Drug+Agent Toxicity by Tissue+Organ|Lung Cancer|Lymphoma|Ovarian Cancer|Unspecified Adult Solid Tumor, Protocol Specific | 1998-02 | PHASE2 |
| NCT01677949 | Masonic Cancer Center, University of Minnesota | Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia | 2013-12 | PHASE2 |
| NCT05504291 | Children´s Oncology Group | Bilateral Retinoblastoma|Childhood Intraocular Retinoblastoma|Group D Retinoblastoma|Stage I Retinoblastoma|Unilateral Retinoblastoma | 2022-11-04 | PHASE2 |
| NCT03901118 | Chipscreen Biosciences, Ltd. | Ovarian Cancer | 2019-07-01 | PHASE2 |
| NCT03792815 | Soonchunhyang University Hospital | Non-Hodgkin´s Lymphoma | 2009-10 | PHASE2 |
| NCT00379457 | European Paediatric Soft Tissue Sarcoma Study Group|Italian Association for Pediatric Hematology Oncology|Children´s Cancer and Leukaemia Group|Dutch Childhood Oncology Group | Sarcoma | 2006-06 | PHASE3 |
| NCT02443077 | National Cancer Institute (NCI) | Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type|Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type | 2016-10-12 | PHASE3 |
| NCT01775475 | AIDS Malignancy Consortium|National Cancer Institute (NCI)|The Emmes Company, LLC|University of Arkansas | AIDS-related Diffuse Large Cell Lymphoma|AIDS-related Diffuse Mixed Cell Lymphoma|AIDS-related Diffuse Small Cleaved Cell Lymphoma|AIDS-related Immunoblastic Large Cell Lymphoma|AIDS-related Lymphoblastic Lymphoma|AIDS-related Peripheral+Systemic Lymphoma|AIDS-related Small Noncleaved Cell Lymphoma|Stage III AIDS-related Lymphoma|Stage IV AIDS-related Lymphoma | 2016-09-15 | PHASE2 |
| NCT03077828 | Northwestern University|Merck Sharp & Dohme LLC|National Cancer Institute (NCI) | Lymphocyte-Rich Classical Hodgkin Lymphoma|Recurrent Lymphocyte-Depleted Classical Hodgkin Lymphoma|Recurrent Mixed Cellularity Classical Hodgkin Lymphoma|Recurrent Nodular Sclerosis Classical Hodgkin Lymphoma|Refractory Lymphocyte-Depleted Classical Hodgkin Lymphoma|Refractory Mixed Cellularity Classical Hodgkin Lymphoma|Refractory Nodular Sclerosis Classical Hodgkin Lymphoma | 2017-04-21 | PHASE2 |
| NCT00732498 | University of Arizona|National Cancer Institute (NCI) | Lymphoma | 2006-05-15 | PHASE2 |
| NCT07009457 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Widespread Small Cell Lung Cancer | 2025-06-16 | PHASE1 |
| NCT00618501 | Asan Medical Center | Leukemia | 2005-10 | PHASE2 |
| NCT03321890 | Sun Yat-sen University | Peripheral T-cell Lymphoma | 2017-03-07 | PHASE2 |
| NCT00002943 | Wake Forest University Health Sciences|National Cancer Institute (NCI) | Extragonadal Germ Cell Tumor|Ovarian Cancer|Testicular Germ Cell Tumor|Unspecified Adult Solid Tumor, Protocol Specific | 1993-02 | PHASE2 |
| NCT00151242 | University of Ulm | Acute Myeloid Leukemia | 2004-07 | PHASE2|PHASE3 |
| NCT00002961 | Children´s Hospital of Philadelphia | Leukemia | 1995-10 | PHASE3 |
| NCT06256237 | Shanghai Pulmonary Hospital, Shanghai, China | Limited Stage Small Cell Lung Cancer | 2024-04-01 | PHASE2 |
| NCT01424839 | University Hospital Muenster|Deutsche Kinderkrebsstiftung|Hannover Medical School|German Society for Pediatric Oncology and Hematology GPOH gGmbH | Intracranial Germ Cell Tumors | 2011-10 | PHASE4 |
| NCT00100477 | US Department of Veterans Affairs|Immunex Corporation|SmithKline Beecham|Amgen | Non-Hodgkin´s Lymphoma|Leukemia | 1998-08 | PHASE2 |
| NCT00002905 | Centro di Riferimento Oncologico - Aviano | Lymphoma | 1995-06 | PHASE2 |
| NCT00025441 | Societe Internationale d´Oncologie Pediatrique|Children´s Cancer and Leukaemia Group|Societe Francaise Oncologie Pediatrique | Ovarian Cancer|Sarcoma|Small Intestine Cancer | 1998-11 | PHASE2 |
| NCT02703272 | Janssen Research & Development, LLC|Pharmacyclics LLC. | Lymphoma, Non-Hodgkin | 2016-07-01 | PHASE3 |
| NCT03794167 | Soonchunhyang University Hospital | Non-hodgkin Lymphoma | 2012-06-01 | PHASE2 |
| NCT00927875 | Bristol-Myers Squibb|Exelixis | Small Cell Lung Carcinoma | 2010-02 | PHASE1 |
| NCT05354700 | Shanghai Henlius Biotech | Small-cell Lung Cancer | 2023-03-29 | PHASE2 |
| NCT04469530 | Emory University|PeachBowl LegACy Fund | Solid Tumor | 2020-09-16 | PHASE2 |
| NCT00004907 | Northwestern University|National Cancer Institute (NCI) | Lymphoma | 1999-10 | PHASE1|PHASE2 |
| NCT00634244 | National Cancer Institute (NCI) | Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Recurrent Adult Acute Myeloid Leukemia | 2008-10 | PHASE2 |
| NCT00983944 | Ohio State University Comprehensive Cancer Center | Lymphoma | 2009-09 | PHASE2 |
| NCT01700946 | St. Jude Children´s Research Hospital|Cookies for Kids´ Cancer|Assisi Foundation | Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood B-Lymphoblastic Lymphoma | 2013-04-15 | PHASE2 |
| NCT00529503 | Seagen Inc.|Genentech, Inc. | Lymphoma, Large B-Cell, Diffuse|Lymphoma, Non-Hodgkin | 2007-09 | PHASE2 |
| NCT00225173 | Stanford University|National Cancer Institute (NCI) | Hodgkin Disease | 2001-10 | PHASE2 |
| NCT00002805 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 1997-08 | PHASE2 |
| NCT01063439 | Inje University | Non Hodgkin´s Lymphoma | 2010-01 | PHASE2 |
| NCT00002488 | Ottawa Regional Cancer Centre | Lymphoma | 1991-12 | PHASE2 |
| NCT02631252 | Alison Sehgal, MD, MS | Leukemia, Acute Myelogenous | 2016-08-18 | PHASE1 |
| NCT00410423 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University|Millennium Pharmaceuticals, Inc. | Relapsed Acute Leukemia|Refractory Acute Leukemia | 2006-01 | PHASE1|PHASE2 |
| NCT03700359 | The First Affiliated Hospital of Guangzhou Medical University | Small Cell Lung Carcinoma | 2019-03-01 | PHASE2 |
| NCT07525466 | Beijing Tongren Hospital | Extranodal NK T Cell Lymphoma|Hemophagocytic Lymphohistiocytosis (HLH) | 2026-04-01 | PHASE1|PHASE2 |
| NCT06172296 | National Cancer Institute (NCI) | Ganglioneuroblastoma, Nodular|Neuroblastoma | 2024-04-19 | PHASE3 |
| NCT05600686 | Joseph Tuscano|National Cancer Institute (NCI)|ADC Therapeutics S.A. | Double-Expressor Lymphoma|High Grade B-Cell Lymphoma With MYC and BCL2 and+or BCL6 Rearrangements|High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements|High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | 2023-05-24 | PHASE2 |
| NCT00567567 | Children´s Oncology Group|National Cancer Institute (NCI) | Localized Resectable Neuroblastoma|Localized Unresectable Neuroblastoma|Recurrent Neuroblastoma|Regional Neuroblastoma|Stage 4 Neuroblastoma|Stage 4S Neuroblastoma | 2007-11-05 | PHASE3 |
| NCT00049439 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) | Lymphoma | 1998-03 | PHASE2 |
| NCT01516567 | Gustave Roussy, Cancer Campus, Grand Paris|Children´s Oncology Group | Primary Mediastinal Large B Cell Lymphoma | 2012-04-01 | PHASE2 |
| NCT02631109 | Beijing Friendship Hospital | Hemophagocytic Lymphohistiocytosis | 2015-12 | PHASE3 |
| NCT04346914 | Lee´s Pharmaceutical Limited | Extensive Stage Small Cell Lung Cancer | 2020-03-08 | PHASE1 |
| NCT03711305 | Jiangsu HengRui Medicine Co., Ltd. | Extensive-stage Small Cell Lung Cancer | 2018-12-30 | PHASE3 |
| NCT00002557 | National Cancer Institute (NCI) | Lymphoma | 1993-06 | PHASE2 |
| NCT00028665 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) | Lymphoma | 2000-06 | PHASE2 |
| NCT00109031 | Swedish Orphan Biovitrum|Amgen | Cancer|Lymphoma|Leukemia | 2005-01 | PHASE3 |
| NCT05453500 | University of Washington|Incyte Corporation | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 2023-03-27 | PHASE2 |
| NCT00060385 | European Organisation for Research and Treatment of Cancer - EORTC | Lymphoma | 2003-03 | PHASE2|PHASE3 |
| NCT00004186 | University of Alabama at Birmingham|National Cancer Institute (NCI) | Lung Cancer | 1996-12 | PHASE1|PHASE2 |
| NCT00006047 | H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI)|Astex Pharmaceuticals, Inc. | Unspecified Adult Solid Tumor, Protocol Specific | 2000-06 | PHASE1 |
| NCT00042978 | National Cancer Institute (NCI) | Extensive Stage Small Cell Lung Cancer|Recurrent Small Cell Lung Cancer | 2003-04 | PHASE2 |
| NCT00667342 | St. Jude Children´s Research Hospital|Genentech, Inc. | Osteosarcoma|Malignant Fibrous Histiocytoma (MFH) of Bone | 2008-06-03 | PHASE2 |
| NCT02964013 | Merck Sharp & Dohme LLC | Neoplasms | 2016-12-13 | PHASE1 |
| NCT06230224 | Regeneron Pharmaceuticals | B-Cell Non-Hodgkin Lymphoma (B-NHL) | 2024-02-15 | PHASE3 |
| NCT00276640 | Societe Internationale d´Oncologie Pediatrique | Primary Central Nervous System Neoplasms | 2004-04-01 | NA |
| NCT00287950 | Children´s Cancer and Leukaemia Group | Neuroblastoma | 1992-09 | NA |
| NCT01993810 | Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology | Stage II Non-Small Cell Lung Cancer AJCC v7|Stage IIA Non-Small Cell Lung Carcinoma AJCC v7|Stage IIB Non-Small Cell Lung Carcinoma AJCC v7|Stage III Non-Small Cell Lung Cancer AJCC v7|Stage IIIA Non-Small Cell Lung Cancer AJCC v7|Stage IIIB Non-Small Cell Lung Cancer AJCC v7 | 2014-02-03 | PHASE3 |
| NCT00193596 | SCRI Development Innovations, LLC|AstraZeneca|Pharmacia and Upjohn|Eli Lilly and Company | Neoplasms, Unknown Primary | 2003-09 | PHASE3 |
| NCT06221683 | Children´s Hospital of Soochow University | AML, Childhood|Acute Myeloid Leukemia | 2024-01-01 | PHASE2 |
| NCT00357305 | National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Basophilic Leukemia|Adult Acute Eosinophilic Leukemia|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Acute Promyelocytic Leukemia (M3)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blastic Phase Chronic Myelogenous Leukemia|Chronic Eosinophilic Leukemia|Chronic Myelomonocytic Leukemia|Chronic Neutrophilic Leukemia|de Novo Myelodysplastic Syndromes|Essential Thrombocythemia|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Polycythemia Vera|Previously Treated Myelodysplastic Syndromes|Primary Myelofibrosis|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Relapsing Chronic Myelogenous Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes | 2006-05 | PHASE1 |
| NCT00589056 | Abramson Cancer Center at Penn Medicine|National Cancer Institute (NCI) | Lung Cancer | 2007-06 | PHASE1|PHASE2 |
| NCT00025402 | III. Medizinische Klinik Mannheim | Leukemia | 1997-07 | PHASE3 |
| NCT00022737 | National Cancer Institute (NCI) | Childhood Acute Lymphoblastic Leukemia in Remission|Recurrent Childhood Acute Lymphoblastic Leukemia | 2002-10 | PHASE3 |
| NCT00612430 | Duke University|Genentech, Inc. | Glioblastoma|Gliosarcoma | 2007-03 | PHASE2 |
| NCT00002634 | Memorial Sloan Kettering Cancer Center | Neuroblastoma | 1995-02 | PHASE2 |
| NCT03018626 | Nanfang Hospital, Southern Medical University | Lymphoma, Large B-Cell, Diffuse | 2017-07-27 | PHASE3 |
| NCT04923776 | Brian Henick, MD | Small-cell Lung Cancer | 2021-09-20 | PHASE2 |
| NCT00187070 | St. Jude Children´s Research Hospital | Lymphoma, Large Cell|Lymphoma, Non-Hodgkin | 1997-12 | NA |
| NCT05863845 | Ruijin Hospital | Diffuse Large B Cell Lymphoma | 2023-06-01 | NA |
| NCT00005802 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia | 1999-06 | PHASE1|PHASE2 |
| NCT03220022 | National Cancer Institute (NCI) | AIDS-Related Lymphoma|Ann Arbor Stage II Diffuse Large B-Cell Lymphoma|Ann Arbor Stage III Diffuse Large B-Cell Lymphoma|Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | 2018-03-16 | PHASE1 |
| NCT00793845 | Samsung Medical Center | Neuroblastoma | 2008-08 | PHASE2 |
| NCT00003619 | Drexel University College of Medicine | Chronic Myeloproliferative Disorders|Leukemia|Myelodysplastic Syndromes|Thrombocytopenia | 1998-02 | PHASE1|PHASE2 |
| NCT00003141 | Children´s Oncology Group|National Cancer Institute (NCI) | Brain Tumors|Central Nervous System Tumors|Neuroblastoma|Sarcoma | 1998-03 | PHASE1 |
| NCT00002757 | Children´s Oncology Group|National Cancer Institute (NCI)|Societe Francaise Oncologie Pediatrique|Children´s Cancer and Leukaemia Group | Leukemia|Lymphoma | 2001-06 | PHASE3 |
| NCT00439361 | M.D. Anderson Cancer Center|Millennium Pharmaceuticals, Inc. | Hodgkin Lymphoma|Lymphoma | 2007-02 | PHASE1 |
| NCT01172912 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Brain and Central Nervous System Tumors|Extragonadal Germ Cell Tumor|Testicular Germ Cell Tumor | 2010-10 | PHASE2 |
| NCT00001337 | National Cancer Institute (NCI) | Diffuse Large B-Cell Lymphoma (DLBCL)|Primary Mediastinal Large B-cell Lymphoma|Burkitt Lymphoma|Anaplastic Large-Cell Lymphoma|Gray Zone Lymphoma | 1993-05-08 | PHASE2 |
| NCT05936086 | shifeng Lou | Hemophagocytic Syndrome | 2023-04-20 | NA |
| NCT05590572 | Second Affiliated Hospital, School of Medicine, Zhejiang University|Chonnam National University|Peking University People´s Hospital|Qilu Hospital of Shandong University|Ruijin Hospital|Shanghai Jiao Tong University Affiliated Sixth People´s Hospital | Osteosarcoma | 2023-01 | PHASE1|PHASE2 |
| NCT00040872 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Neuroblastoma | 2000-06 | PHASE2 |
| NCT01946529 | St. Jude Children´s Research Hospital|University of Tennessee|University of Florida|Nemours Children´s Clinic | Desmoplastic Small Round Cell Tumor|Ewing Sarcoma of Bone or Soft Tissue|Localized Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor|Metastatic Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor | 2013-12-27 | PHASE2 |
| NCT01746173 | Dana-Farber Cancer Institute|Massachusetts General Hospital|Beth Israel Deaconess Medical Center | T-cell Non-Hodgkin Lymphoma | 2013-07 | PHASE2 |
| NCT00667615 | Memorial Sloan Kettering Cancer Center|Merck Sharp & Dohme LLC|Northwestern University|Endeavor Health|Weill Medical College of Cornell University | Hodgkin´s Disease|Lymphoma | 2008-04 | PHASE1|PHASE2 |
| NCT00216125 | Nasser Hanna, M.D.|Sanofi|Walther Cancer Institute | Non-Small Cell Lung Cancer | 2002-02 | PHASE3 |
| NCT00198991 | Goethe University|Deutsche Krebshilfe e.V., Bonn (Germany)|German Federal Ministry of Education and Research | Adult Acute Lymphocytic Leukemia | 2003-04 | PHASE4 |
| NCT05384821 | Centre Oscar Lambret | Wilms Tumor | 2022-09-14 | PHASE1|PHASE2 |
| NCT00057811 | Children´s Oncology Group|National Cancer Institute (NCI) | Childhood Burkitt Lymphoma|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Stage I Childhood Large Cell Lymphoma|Stage I Childhood Small Noncleaved Cell Lymphoma|Stage II Childhood Large Cell Lymphoma|Stage II Childhood Small Noncleaved Cell Lymphoma|Stage III Childhood Large Cell Lymphoma|Stage III Childhood Small Noncleaved Cell Lymphoma|Stage IV Childhood Large Cell Lymphoma|Stage IV Childhood Small Noncleaved Cell Lymphoma|Untreated Childhood Acute Lymphoblastic Leukemia | 2004-06 | PHASE2 |
| NCT03229616 | Nanfang Hospital, Southern Medical University|Guangzhou First People´s Hospital|Zhujiang Hospital|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|Third Affiliated Hospital, Sun Yat-Sen University|Peking University People´s Hospital | Autologous Hematopoietic Stem Cell Transplantation|Diffuse Large B-cell Lymphoma|Conditioning | 2017-07-05 | PHASE2|PHASE3 |
| NCT00047320 | Children´s Oncology Group|National Cancer Institute (NCI) | Brain Tumor|Central Nervous System Tumors|Childhood Germ Cell Tumor | 2004-01 | PHASE2 |
| NCT00357500 | Dana-Farber Cancer Institute|National Cancer Institute (NCI)|Boston Children´s Hospital | Central Nervous System Tumor, Pediatric|Leukemia|Lymphoma|Neuroblastoma|Sarcoma|Unspecified Childhood Solid Tumor, Protocol Specific | 2005-01 | PHASE2 |
| NCT03420963 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Recurrent Cutaneous Melanoma|Recurrent Lip and Oral Cavity Carcinoma|Recurrent Malignant Endocrine Neoplasm|Recurrent Malignant Female Reproductive System Neoplasm|Recurrent Malignant Male Reproductive System Neoplasm|Recurrent Malignant Mesothelioma|Recurrent Malignant Neoplasm of Multiple Primary Sites|Recurrent Malignant Oral Neoplasm|Recurrent Malignant Pharyngeal Neoplasm|Recurrent Malignant Skin Neoplasm|Recurrent Malignant Soft Tissue Neoplasm|Recurrent Malignant Solid Neoplasm|Recurrent Malignant Thyroid Gland Neoplasm|Recurrent Malignant Urinary System Neoplasm|Refractory Cutaneous Melanoma|Refractory Malignant Bone Neoplasm|Refractory Malignant Endocrine Neoplasm|Refractory Malignant Female Reproductive System Neoplasm|Refractory Malignant Male Reproductive System Neoplasm|Refractory Malignant Mesothelioma|Refractory Malignant Neoplasm of Multiple Primary Sites|Refractory Malignant Oral Neoplasm|Refractory Malignant Pharyngeal Neoplasm|Refractory Malignant Skin Neoplasm|Refractory Malignant Soft Tissue Neoplasm|Refractory Malignant Solid Neoplasm|Refractory Malignant Thyroid Gland Neoplasm|Refractory Malignant Urinary System Neoplasm | 2018-08-31 | PHASE1 |
| NCT04139304 | AIDS Malignancy Consortium|National Cancer Institute (NCI)|Janssen Scientific Affairs, LLC|Montefiore Medical Center|Memorial Sloan Kettering Cancer Center|AIDS and Cancer Specimen Resource|The Emmes Company, LLC | Plasmablastic Lymphoma|Ann Arbor Stage I Diffuse Large B-Cell Lymphoma|Ann Arbor Stage II Diffuse Large B-Cell Lymphoma|Ann Arbor Stage III Diffuse Large B-Cell Lymphoma|Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | 2021-05-24 | EARLY_PHASE1 |
| NCT00049036 | National Cancer Institute (NCI) | AIDS-related Diffuse Large Cell Lymphoma|AIDS-related Immunoblastic Large Cell Lymphoma|AIDS-related Peripheral+Systemic Lymphoma|AIDS-related Small Noncleaved Cell Lymphoma | 2003-03 | PHASE2 |
| NCT02502708 | NewLink Genetics Corporation | Glioblastoma Multiforme|Glioma|Gliosarcoma|Malignant Brain Tumor|Ependymoma|Medulloblastoma|Diffuse Intrinsic Pontine Glioma|Primary CNS Tumor | 2015-10 | PHASE1 |
| NCT03980925 | Grupo Espanol de Tumores Neuroendocrinos | Neuroendocrine Tumors|Neuroendocrine Neoplasm|Gastroenteropancreatic Neuroendocrine Tumor | 2019-10-11 | PHASE2 |
| NCT00143455 | Pfizer | Small Cell Lung Carcinoma | 2002-06 | PHASE3 |
| NCT02518750 | St. Jude Children´s Research Hospital|Novartis Pharmaceuticals|Spectrum Pharmaceuticals, Inc | Acute Lymphoblastic Leukemia|Lymphoma, Non-Hodgkin´s|Leukemia, T-Cell|Leukemia, B-Cell | 2016-11-23 | PHASE2 |
| NCT03141359 | Wake Forest University Health Sciences|Atrium Health Levine Cancer Institute|AstraZeneca | Lung Cancer Stage II|Lung Cancer Stage III|Non Small Cell Lung Cancer | 2017-05-12 | PHASE2 |
| NCT00887159 | National Cancer Institute (NCI) | Extensive Stage Small Cell Lung Carcinoma|Recurrent Small Cell Lung Carcinoma | 2009-07-16 | PHASE2 |
| NCT00003815 | Scotland and Newcastle Lymphoma Group | Lymphoma | 1994-06 | PHASE3 |
| NCT00066482 | Children´s Oncology Group|National Cancer Institute (NCI) | Childhood Germ Cell Tumor|Extragonadal Germ Cell Tumor | 2004-07 | NA |
| NCT05142865 | Huazhong University of Science and Technology | Advanced or Metastatic EP-NEC | 2022-01-14 | PHASE2 |
| NCT04684017 | Shanghai Chest Hospital | SCLC|Anlotinib | 2019-05-01 | PHASE2 |
| NCT02553460 | St. Jude Children´s Research Hospital|Gateway for Cancer Research|Baylor College of Medicine | Acute Lymphoblastic Leukemia | 2016-01-29 | PHASE1|PHASE2 |
| NCT00426101 | Karolinska University Hospital|Meyer Children´s Hospital IRCCS|Leiden University Medical Center|Children´s Hospital Medical Center, Cincinnati|Ehime University Graduate School of Medicine|Universit?tsklinikum Hamburg-Eppendorf|Baylor College of Medicine|Great Ormond Street Hospital for Children NHS Foundation Trust|St. Anna Kinderkrebsforschung|Hospital de Cruces|Hospital JP Garrahan | Hemophagocytic Lymphohistiocytosis | 2004-01 | PHASE3 |
| NCT00365755 | Children´s Cancer and Leukaemia Group | Neuroblastoma | | PHASE3 |
| NCT00025428 | Societe Internationale d´Oncologie Pediatrique|Children´s Cancer and Leukaemia Group | Neuroblastoma | 2000-12 | PHASE3 |
| NCT07502300 | Sichuan Baili Pharmaceutical Co., Ltd.|Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. | Extensive-stage Small-cell Lung Cancer | 2026-04 | PHASE3 |
| NCT00195871 | Centre Henri Becquerel | Lymphoblastic Lymphoma | 2004-02 | PHASE2 |
| NCT01569204 | University of Cologne | Hodgkin Lymphoma | 2012-10 | PHASE2 |
| NCT00002898 | Societe Internationale d´Oncologie Pediatrique | Childhood Malignant Fibrous Histiocytoma of Bone|Sarcoma | 1995-01 | PHASE3 |
| NCT00002643 | National Cancer Institute (NCI)|Children´s Cancer Group | Neutropenia|Sarcoma | 1995-04 | PHASE2 |
| NCT04610684 | Jeffrey Clarke|Genentech, Inc.|Duke University | Small-cell Lung Cancer|Brain Metastases | 2021-01-05 | PHASE2 |
| NCT00808899 | St. Jude Children´s Research Hospital | Neuroblastoma | 2008-12 | PHASE2 |
| NCT05019716 | National Cancer Institute (NCI) | Advanced NUT Carcinoma|Metastatic NUT Carcinoma|Unresectable NUT Carcinoma | 2022-07-13 | PHASE1|PHASE2 |
| NCT04484506 | Peking University|Peking University Cancer Hospital & Institute|Peking University International Hospital|Hebei Medical University Fourth Hospital|Jiangxi Provincial Cancer Hospital | NK+T Cell Lymphoma Nos | 2011-10-20 | PHASE2 |
| NCT00002638 | University of Nebraska | Leukemia | 1995-03 | PHASE2 |
| NCT00387699 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) | Lung Cancer | 2006-10 | PHASE2 |
| NCT03519971 | AstraZeneca | Non-Small Cell Lung Cancer | 2018-03-29 | PHASE3 |
| NCT07097948 | Shanghai Pulmonary Hospital, Shanghai, China | Postoperative Incidental Small Cell Lung Cancer|Toripalimab Adjuvant Therapy Evaluation | 2025-08 | PHASE2 |
| NCT00005987 | Masonic Cancer Center, University of Minnesota | Multiple Myeloma and Plasma Cell Neoplasm | 2000-08 | PHASE2 |
| NCT02349178 | Medical College of Wisconsin|American Family Children´s Hospital|Nationwide Children´s Hospital | Leukemia, Acute Lymphoblastic|Acute Myeloid Leukemia | 2014-12-08 | PHASE2 |
| NCT02686346 | The Lymphoma Academic Research Organisation|Millennium Pharmaceuticals, Inc. | Hodgkin Disease | 2016-03 | PHASE1|PHASE2 |
| NCT00025272 | Wake Forest University Health Sciences|National Cancer Institute (NCI) | Lung Cancer | 2001-11-01 | PHASE2 |
| NCT03699956 | EpicentRx, Inc. | Carcinoma, Small Cell Lung | 2018-12-24 | PHASE3 |
| NCT01222572 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital | Non-small Cell Lung Cancer|Lung Cancer|NSCLC | 2010-12 | PHASE1|PHASE2 |
| NCT00003996 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Brain and Central Nervous System Tumors | 1999-05 | PHASE2 |
| NCT00002829 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Lymphoma | 1994-02 | PHASE2 |
| NCT02018861 | Incyte Corporation | B-Cell Malignancies | 2016-09-22 | PHASE1|PHASE2 |
| NCT02549261 | Biotech Pharmaceutical Co., Ltd. | Non-small Cell Lung Cancer | 2011-03 | NA |
| NCT04665765 | City of Hope Medical Center|National Cancer Institute (NCI) | Diffuse Large B-Cell Lymphoma Unclassifiable|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma|Recurrent Transformed B-Cell Non-Hodgkin Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma|Refractory Transformed B-Cell Non-Hodgkin Lymphoma | 2021-01-18 | PHASE2 |
| NCT00003436 | Medical Research Council | Leukemia|Myelodysplastic Syndromes | 1998-07 | PHASE3 |
| NCT00006184 | National Cancer Institute (NCI) | Multiple Myeloma | 2001-02-08 | PHASE2 |
| NCT00187005 | St. Jude Children´s Research Hospital | Acute Lymphoblastic Leukemia | 1998-07 | PHASE3 |
| NCT00003299 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|North Central Cancer Treatment Group|Eastern Cooperative Oncology Group|SWOG Cancer Research Network | Lung Cancer | 1998-04 | PHASE3 |
| NCT06406465 | National Cancer Institute (NCI) | Carcinoma, Neuroendocrine|Tumor, Neuroendocrine|Tumors, Neuroendocrine|Neuroendocrine; Carcinoma|Small Cell; Receptors | 2026-05-13 | PHASE2 |
| NCT01864109 | Memorial Sloan Kettering Cancer Center | Newly Diagnosed Ewing Sarcoma | 2013-05 | PHASE2 |
| NCT06739928 | Guangzhou Institute of Respiratory Disease | Small Cell Lung Cancer Extensive Stage | 2025-01-01 | PHASE2 |
| NCT06039371 | University of Washington|National Cancer Institute (NCI) | Castration-Resistant Prostate Carcinoma|Metastatic Prostate Adenocarcinoma|Stage IVB Prostate Cancer AJCC v8 | 2024-05-21 | PHASE2 |
| NCT00007865 | University of Nebraska|National Cancer Institute (NCI) | Lymphoma | 2000-09-01 | PHASE2 |
| NCT00613626 | Hoosier Cancer Research Network|AstraZeneca | Small Cell Lung Cancer | 2008-01 | PHASE2 |
| NCT03328104 | Emory University | Lymphoblastic Leukemia|Lymphoblastic Lymphoma | 2018-07-24 | PHASE1 |
| NCT00004176 | Washington University School of Medicine|National Cancer Institute (NCI) | Drug+Agent Toxicity by Tissue+Organ|Lung Cancer|Radiation Toxicity | 1998-10 | PHASE2 |
| NCT00061893 | Children´s Oncology Group|National Cancer Institute (NCI) | Sarcoma | 2004-04 | PHASE2 |
| NCT00288626 | National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN) | Relapsing-Remitting Multiple Sclerosis | 2006-07 | PHASE2 |
| NCT04432714 | The First Affiliated Hospital with Nanjing Medical University | DLBCL|Untreated|MYC Gene Rearrangement | 2020-06-09 | PHASE1|PHASE2 |
| NCT04833114 | GWT-TUD GmbH|Hoffmann-La Roche | Relapsed Diffuse Large B-cell Lymphoma|Refractory Diffuse Large B-Cell Lymphoma | 2021-04-30 | PHASE3 |
| NCT04177004 | City of Hope Medical Center|National Cancer Institute (NCI) | Allogeneic Hematopoietic Stem Cell Transplant Recipient|Hematopoietic and Lymphoid Cell Neoplasm | 2021-04-30 | PHASE1 |
| NCT00720109 | National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | 2008-07-14 | PHASE2|PHASE3 |
| NCT05533775 | Hoffmann-La Roche | Mature B-Cell Non-Hodgkin Lymphoma | 2022-11-16 | PHASE1|PHASE2 |
| NCT00554463 | Radiation Therapy Oncology Group|National Cancer Institute (NCI)|Cancer and Leukemia Group B | Lung Cancer | 2008-01 | PHASE2 |
| NCT04804007 | Nabil Adra | Germ Cell Tumor|Non-seminomatous Germ Cell Tumor|Ovarian Germ Cell Tumor | 2021-03-03 | PHASE2 |
| NCT00972101 | M.D. Anderson Cancer Center | Stem Cell Transplantation|Leukemia|Lymphoma|Pediatric Disorders | 2009-09 | PHASE1 |
| NCT03567642 | Memorial Sloan Kettering Cancer Center | Lung Cancer | 2018-06-12 | PHASE1 |
| NCT02784054 | Samsung Medical Center | Intracranial Non-germinomatous Germ Cell Tumor | 2014-04 | PHASE2 |
| NCT03118466 | Massachusetts General Hospital|Celgene | AML | 2017-09-25 | PHASE2 |
| NCT00018954 | National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) | Leukemia|Lymphoma | 1992-10 | PHASE2 |
| NCT04696575 | Roswell Park Cancer Institute | Extensive Stage Lung Small Cell Carcinoma | 2021-07-02 | PHASE2 |
| NCT06769971 | Sichuan University | Small Cell Lung Cancer | 2025-02-01 | PHASE2 |
| NCT04101357 | BioNTech SE | Solid Tumor|Extensive-stage Small Cell Lung Cancer | 2020-06-19 | PHASE1|PHASE2 |
| NCT00450801 | University of Miami | Lymphoma | 2004-04 | PHASE2 |
| NCT01959477 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) | Adult Grade III Lymphomatoid Granulomatosis|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Childhood Burkitt Lymphoma|Childhood Diffuse Large Cell Lymphoma|Childhood Grade III Lymphomatoid Granulomatosis|Childhood Immunoblastic Large Cell Lymphoma|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|Contiguous Stage II Marginal Zone Lymphoma|Contiguous Stage II Small Lymphocytic Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 1 Follicular Lymphoma|Noncontiguous Stage II Grade 2 Follicular Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Noncontiguous Stage II Marginal Zone Lymphoma|Noncontiguous Stage II Small Lymphocytic Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent+Refractory Childhood Hodgkin Lymphoma|Refractory Hairy Cell Leukemia|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage I Adult Burkitt Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Mixed Cell Lymphoma|Stage I Adult Diffuse Small Cleaved Cell Lymphoma|Stage I Adult Hodgkin Lymphoma|Stage I Adult Immunoblastic Large Cell Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage I Adult T-cell Leukemia+Lymphoma|Stage I Childhood Anaplastic Large Cell Lymphoma|Stage I Childhood Hodgkin Lymphoma|Stage I Childhood Large Cell Lymphoma|Stage I Childhood Lymphoblastic Lymphoma|Stage I Childhood Small Noncleaved Cell Lymphoma|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma|Stage I Grade 1 Follicular Lymphoma|Stage I Grade 2 Follicular Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage I Marginal Zone Lymphoma|Stage I Small Lymphocytic Lymphoma|Stage IA Mycosis Fungoides+Sezary Syndrome|Stage IB Mycosis Fungoides+Sezary Syndrome|Stage II Adult Hodgkin Lymphoma|Stage II Adult T-cell Leukemia+Lymphoma|Stage II Childhood Anaplastic Large Cell Lymphoma|Stage II Childhood Hodgkin Lymphoma|Stage II Childhood Large Cell Lymphoma|Stage II Childhood Lymphoblastic Lymphoma|Stage II Childhood Small Noncleaved Cell Lymphoma|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IIA Mycosis Fungoides+Sezary Syndrome|Stage IIB Mycosis Fungoides+Sezary Syndrome|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Adult T-cell Leukemia+Lymphoma|Stage III Childhood Anaplastic Large Cell Lymphoma|Stage III Childhood Hodgkin Lymphoma|Stage III Childhood Large Cell Lymphoma|Stage III Childhood Lymphoblastic Lymphoma|Stage III Childhood Small Noncleaved Cell Lymphoma|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Small Lymphocytic Lymphoma|Stage IIIA Mycosis Fungoides+Sezary Syndrome|Stage IIIB Mycosis Fungoides+Sezary Syndrome|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-cell Leukemia+Lymphoma|Stage IV Childhood Anaplastic Large Cell Lymphoma|Stage IV Childhood Hodgkin Lymphoma|Stage IV Childhood Large Cell Lymphoma|Stage IV Childhood Lymphoblastic Lymphoma|Stage IV Childhood Small Noncleaved Cell Lymphoma|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Small Lymphocytic Lymphoma|Stage IVA Mycosis Fungoides+Sezary Syndrome|Stage IVB Mycosis Fungoides+Sezary Syndrome|T-cell Large Granular Lymphocyte Leukemia|Testicular Lymphoma|Waldenstr?m Macroglobulinemia | 2014-03 | EARLY_PHASE1 |
| NCT01411267 | Therapeutic Advances in Childhood Leukemia Consortium|Ambit Biosciences Corporation | Lymphoblastic Leukemia, Acute, Childhood|Myelogenous Leukemia, Acute, Childhood | 2011-09-01 | PHASE1 |
| NCT00002665 | SWOG Cancer Research Network|National Cancer Institute (NCI) | Leukemia|Neutropenia|Thrombocytopenia | 1995-07 | PHASE2 |
| NCT00632827 | University of California, San Francisco|Eisai Inc.|Washington University School of Medicine | Peripheral T-Cell Lymphoma | 2008-07-01 | PHASE2 |
| NCT02094794 | City of Hope Medical Center|National Cancer Institute (NCI) | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia | 2014-05-12 | PHASE2 |
| NCT00829205 | Cancer Research UK | Lymphoma | 2009-01 | PHASE1|PHASE2 |
| NCT01294670 | Memorial Sloan Kettering Cancer Center|Merck Sharp & Dohme LLC|Phoenix Children´s Hospital|Milton S. Hershey Medical Center|Johns Hopkins University|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Children´s Hospital Colorado|University of Florida|Alberta Children´s Hospital|M.D. Anderson Cancer Center|Dana-Farber Cancer Institute|Children´s Mercy Hospital Kansas City|Johns Hopkins All Children´s Hospital|Arnold Palmer Hospital for Children | Solid Tumors|Relapsed+Refractory Sarcomas | 2011-02-09 | PHASE1|PHASE2 |
| NCT00315705 | Genzyme, a Sanofi Company | Acute Lymphoblastic Leukemia|Acute Myelogenous Leukemia|Relapsed Leukemia | 2006-03 | PHASE1|PHASE2 |
| NCT00276809 | German CLL Study Group | Chronic Lymphocytic Leukemia | 2001-06 | PHASE2 |
| NCT00002494 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Leukemia|Lymphoma | 1992-05 | PHASE2 |
| NCT03963193 | Henan Cancer Hospital | Gastrointestinal Neuroendocrine Tumor | 2019-06-01 | PHASE2 |
| NCT03135977 | Sichuan Cancer Hospital and Research Institute | Extensive-stage Small Cell Lung Cancer|Lung Cancer | 2017-03-01 | PHASE2 |
| NCT00924209 | National Cancer Institute (NCI) | NSCLC|Stage IIIA (N2) | 2009-03 | PHASE2 |
| NCT00439556 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | CD20 Positive|Hematopoietic and Lymphoid Cell Neoplasm|Lymphocytic Neoplasm|Lymphoma | 2007-02-13 | PHASE2 |
| NCT00043979 | National Cancer Institute (NCI) | Sarcoma | 2002-09-19 | PHASE2 |
| NCT01887340 | Gustave Roussy, Cancer Campus, Grand Paris | Seminoma | 2013-06 | PHASE2 |
| NCT01260714 | National Cancer Institute (NCI) | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Adult Acute Basophilic Leukemia|Adult Acute Eosinophilic Leukemia|Adult Acute Megakaryoblastic Leukemia|Adult Acute Monoblastic Leukemia|Adult Acute Monocytic Leukemia|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With Maturation|Adult Acute Myeloid Leukemia With Minimal Differentiation|Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1|Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL|Adult Acute Myeloid Leukemia Without Maturation|Adult Acute Myelomonocytic Leukemia|Adult Erythroleukemia|Adult Pure Erythroid Leukemia|Alkylating Agent-Related Acute Myeloid Leukemia|Recurrent Adult Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia | 2010-12 | PHASE1 |
| NCT00025649 | European Infant Neuroblastoma Study Group - 1999 | Neuroblastoma | 1999-07 | PHASE2 |
| NCT03017326 | University of Birmingham|Fundació Institut Germans Trias i Pujol|University Hospital Munich|University Hospital, Bonn|University of Kiel|University Hospital Tuebingen|University of Padova|Ludwig-Maximilians - University of Munich|Medical University of Gdansk|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|Motol University Hospital|Rennes University Hospital|Children´s University Hospital, Ireland|University of Oslo|Princess Maxima Center for Pediatric Oncology|Andaluz Health Service|Swiss Pediatric Oncology Group|Gothia Forum - Center for Clinical Trial|The Leeds Teaching Hospitals NHS Trust|Bambino Gesù Hospital and Research Institute|Newcastle University|Experimental Cancer Medicine Centres|XenTech, Evry | Hepatoblastoma|Carcinoma, Hepatocellular | 2017-08-24 | PHASE3 |
| NCT05116007 | Akeso | SCLC, Extensive Stage | 2021-03-29 | PHASE1 |
| NCT01300793 | University of California, San Francisco|Millennium Pharmaceuticals, Inc. | Non-Hodgkin´s Lymphoma|B-cell Lymphoma | 2007-05 | PHASE1 |
| NCT00003243 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) | Leukemia|Lymphoma|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 1998-01 | PHASE1 |
| NCT00453232 | Cambridge University Hospitals NHS Foundation Trust | Extragonadal Germ Cell Tumor|Teratoma|Testicular Germ Cell Tumor | 2004-08 | PHASE2 |
| NCT00002611 | Children´s Oncology Group|National Cancer Institute (NCI) | Kidney Cancer | 1995-07 | PHASE3 |
| NCT00002798 | National Cancer Institute (NCI) | Childhood Acute Erythroleukemia (M6)|Childhood Acute Megakaryocytic Leukemia (M7)|Childhood Acute Monoblastic Leukemia (M5a)|Childhood Acute Monocytic Leukemia (M5b)|Childhood Acute Myeloblastic Leukemia With Maturation (M2)|Childhood Acute Myeloblastic Leukemia Without Maturation (M1)|Childhood Acute Myelomonocytic Leukemia (M4)|Childhood Myelodysplastic Syndromes|Chronic Myelomonocytic Leukemia|de Novo Myelodysplastic Syndromes|Refractory Anemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Excess Blasts in Transformation|Refractory Anemia With Ringed Sideroblasts|Secondary Myelodysplastic Syndromes|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies | 1996-08 | PHASE3 |
| NCT00006363 | National Cancer Institute (NCI) | Adult Acute Basophilic Leukemia|Adult Acute Eosinophilic Leukemia|Adult Acute Erythroid Leukemia (M6)|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Childhood Acute Basophilic Leukemia|Childhood Acute Eosinophilic Leukemia|Childhood Acute Erythroleukemia (M6)|Childhood Acute Megakaryocytic Leukemia (M7)|Childhood Acute Minimally Differentiated Myeloid Leukemia (M0)|Childhood Acute Monoblastic Leukemia (M5a)|Childhood Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5)|Childhood Acute Monocytic Leukemia (M5b)|Childhood Acute Myeloblastic Leukemia With Maturation (M2)|Childhood Acute Myeloblastic Leukemia Without Maturation (M1)|Childhood Acute Myelomonocytic Leukemia (M4)|Childhood Myelodysplastic Syndromes|de Novo Myelodysplastic Syndromes|Untreated Adult Acute Myeloid Leukemia|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies | 2000-11 | PHASE3 |
| NCT06375109 | Beijing Chest Hospital, Capital Medical University | Limited-stage Small-cell Lung Cancer | 2024-04-16 | PHASE2 |
| NCT04679012 | Weill Medical College of Cornell University|Genentech, Inc. | Richter Syndrome|Chronic Lymphocytic Leukemia | 2021-09-24 | PHASE2 |
| NCT00003541 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Lymphoma | 1998-06 | PHASE1|PHASE2 |
| NCT00572169 | University of Arkansas | Multiple Myeloma | 2006-11 | PHASE3 |
| NCT07083375 | Zhijie Wang|Peking University Cancer Hospital & Institute|Hebei Medical University Fourth Hospital|Tianjin Medical University Cancer Institute and Hospital|Renmin Hospital of Wuhan University|Wuhan TongJi Hospital|Peking University People´s Hospital|Shanxi Province Cancer Hospital | Extensive Small Cell Lung Cancer | 2025-08-01 | PHASE2 |
| NCT02015728 | Seattle Children´s Hospital|Cures Within Reach | Recurrent Childhood Brain Tumor | 2013-12 | NA |
| NCT00689169 | Lymphoma Study Association|Bayer | Lymphoma, Large Cell, Diffuse | 2007-08 | PHASE2 |
| NCT00006054 | Fairview University Medical Center | Immunologic Deficiency Syndromes|Chediak-Higashi Syndrome|Common Variable Immunodeficiency|Graft Versus Host Disease|X-Linked Lymphoproliferative Syndrome|Familial Erythrophagocytic Lymphohistiocytosis|Hemophagocytic Lymphohistiocytosis|X-linked Agammaglobulinemia|Wiskott-Aldrich Syndrome|Chronic Granulomatous Disease|X-linked Hyper IgM Syndrome|Severe Combined Immunodeficiency|Leukocyte Adhesion Deficiency Syndrome|Virus-Associated Hemophagocytic Syndrome | 2000-03 | NA |
| NCT00047138 | University of Leicester|Societe Francaise Oncologie Pediatrique|Children´s Cancer and Leukaemia Group|German Society for Pediatric Oncology and Hematology GPOH gGmbH | Kidney Cancer | 2001-01 | PHASE3 |
| NCT00083538 | University of Arkansas | Multiple Myeloma | 2001-02 | PHASE2 |
| NCT00026208 | Stanford University | Lymphoma, Hodgkin Disease|Lymphoma|Hodgkin Disease|Lymphoma: Hodgkin | 2001-06 | PHASE2 |
| NCT00003215 | Swiss Cancer Institute | Lymphoma | 1997-04 | PHASE3 |
| NCT00049569 | National Cancer Institute (NCI) | L1 Childhood Acute Lymphoblastic Leukemia|L2 Childhood Acute Lymphoblastic Leukemia|Non-T, Non-B Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|T-cell Childhood Acute Lymphoblastic Leukemia | 2003-01 | NA |
| NCT00137995 | Lymphoma Study Association | Lymphoma, Large-Cell, Diffuse | 2003-06 | PHASE3 |
| NCT00006122 | European Organisation for Research and Treatment of Cancer - EORTC | Leukemia | 2000-06 | PHASE2 |
| NCT00209222 | European Mantle Cell Lymphoma Network|German Low Grade Lymphoma Study Group|Lymphoma Study Association | Lymphoma, Mantle-Cell | 2004-07 | PHASE3 |
| NCT00165451 | Dana-Farber Cancer Institute | Neoplasms | 2001-06 | PHASE2 |
| NCT04560972 | City of Hope Medical Center|National Cancer Institute (NCI) | Extensive Stage Lung Small Cell Carcinoma | 2021-05-28 | PHASE1 |
| NCT06732258 | Sichuan University | Extensive-stage Small-cell Lung Cancer | 2025-01-10 | PHASE1 |
| NCT00006040 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Leukemia|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 2000-04 | PHASE1 |
| NCT02896582 | The Lymphoma Academic Research Organisation | Mantle Cell Lymphoma | 2016-11-29 | PHASE2 |
| NCT00005793 | H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI)|SmithKline Beecham | Leukemia | 1999-07 | PHASE1|PHASE2 |
| NCT00009815 | University of Pittsburgh|National Cancer Institute (NCI) | Unspecified Adult Solid Tumor, Protocol Specific | 1999-12 | PHASE1 |
| NCT00080925 | National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 2004-02 | PHASE1 |
| NCT07538258 | Yayi He | Limited-stage Small Cell Lung Cancer (LS-SCLC) | 2026-04-20 | PHASE2 |
| NCT00045617 | SWOG Cancer Research Network|National Cancer Institute (NCI) | Lung Cancer | 2003-01 | PHASE2 |
| NCT02797717 | GALIA AVRAHAMI|University of Giessen | Classical Hodgkins Lymphoma in Children and Adolescents. | 2015-11 | NA |
| NCT00005803 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Prolymphocytic Leukemia|Recurrent Adult Hodgkin Lymphoma|Recurrent Childhood Hodgkin Lymphoma|Recurrent Childhood Non-Hodgkin Lymphoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Non-Hodgkin Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hodgkin Lymphoma|Refractory Non-Hodgkin Lymphoma|Refractory Small Lymphocytic Lymphoma|T-Cell Chronic Lymphocytic Leukemia|T-Cell Prolymphocytic Leukemia | 1999-09 | PHASE1|PHASE2 |
| NCT00131027 | Japan Adult Leukemia Study Group | Lymphoblastic Leukemia, Acute | 2002-09 | PHASE3 |
| NCT00430118 | University Hospital Schleswig-Holstein | Leukemia | 2000-07 | PHASE3 |
| NCT00369317 | Children´s Oncology Group|National Cancer Institute (NCI) | Childhood Acute Basophilic Leukemia|Childhood Acute Eosinophilic Leukemia|Childhood Acute Erythroleukemia (M6)|Childhood Acute Megakaryocytic Leukemia (M7)|Childhood Acute Minimally Differentiated Myeloid Leukemia (M0)|Childhood Acute Monoblastic Leukemia (M5a)|Childhood Acute Monocytic Leukemia (M5b)|Childhood Acute Myeloblastic Leukemia With Maturation (M2)|Childhood Acute Myeloblastic Leukemia Without Maturation (M1)|Childhood Acute Myelomonocytic Leukemia (M4)|Childhood Myelodysplastic Syndromes|de Novo Myelodysplastic Syndromes|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies | 2007-03 | PHASE3 |
| NCT04301076 | National Cancer Institute (NCI) | Acute Adult T-Cell Leukemia+Lymphoma|Adult T-Cell Leukemia+Lymphoma|Chronic Adult T-Cell Leukemia+Lymphoma|HTLV-1 Infection | 2021-08-31 | PHASE1 |
| NCT01104025 | Children´s Hospital Medical Center, Cincinnati | Hemophagocytic Lymphohistiocytosis | 2010-04 | PHASE2 |
| NCT06485908 | Assistance Publique Hopitaux De Marseille | Medulloblastoma|Ependymoma | 2024-10 | PHASE1|PHASE2 |
| NCT02605421 | Masonic Cancer Center, University of Minnesota | Neuroblastoma | 2016-06 | PHASE2 |
| NCT04696939 | Shanghai Pulmonary Hospital, Shanghai, China | Small-cell Lung Cancer|Neoadjuvant Therapy | 2021-01 | PHASE2 |
| NCT02099175 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|Regione Lombardia | Sinonasal Tumors | 2013-11 | PHASE2 |
| NCT00253552 | OHSU Knight Cancer Institute|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases|Sarcoma | 2004-05 | NA |
| NCT00004169 | Northwestern University|National Cancer Institute (NCI) | Lymphoma | 1993-11 | PHASE2 |
| NCT00534469 | City of Hope Medical Center|National Cancer Institute (NCI) | Leukemia | 2000-02-08 | PHASE2 |
| NCT02580994 | European Organisation for Research and Treatment of Cancer - EORTC|Merck Sharp & Dohme LLC | Small Cell Lung Cancer (SCLC) | 2017-12-08 | PHASE2 |
| NCT01481272 | Polish Lymphoma Research Group | Diffuse Large B Cell Lymphoma | 2011-11 | PHASE2 |
| NCT00483561 | University of Nebraska|National Cancer Institute (NCI) | Prostate Cancer | 2004-01 | PHASE2 |
| NCT00025103 | Children´s Cancer and Leukaemia Group | Kidney Cancer | 2001-05 | PHASE2 |
| NCT05049473 | PETHEMA Foundation|Grupo Espa?ol de Linfomas y Transplante Autólogo de Médula ósea | Mature B-Cell Leukemia Burkitt Type|Burkitt Lymphoma (BL)|Unclassifiable Lymphoma Between DCBL and BL | 2014-01 | PHASE2 |
| NCT03719105 | New York Medical College|University of Alabama at Birmingham | NK-Cell Lymphoma|NK-Cell Leukemia|Peripheral T Cell Lymphoma | 2019-03-01 | EARLY_PHASE1 |
| NCT00083161 | Gundersen Lutheran Health System | Lung Cancer | 2003-06 | PHASE2 |
| NCT00002550 | Radiation Therapy Oncology Group|National Cancer Institute (NCI)|SWOG Cancer Research Network|Eastern Cooperative Oncology Group|Cancer and Leukemia Group B|North Central Cancer Treatment Group|NCIC Clinical Trials Group | Lung Cancer | 1994-03 | PHASE3 |
| NCT01500161 | Texas Oncology Cancer Center | Acute Myelogenous Leukemia|Acute Lymphocytic Leukemia|Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Hodgkins Disease|Non-Hodgkins Lymphoma|Aplastic Anemia|Multiple Myeloma|Myelodysplastic Syndrome | 2011-11 | PHASE2 |
| NCT01435018 | Advancing Clinical Therapeutics Globally for HIV+AIDS and Other Infections|National Institute of Allergy and Infectious Diseases (NIAID)|National Cancer Institute (NCI)|National Institute of Dental and Craniofacial Research (NIDCR)|AIDS Malignancy Consortium | HIV-1 Infection | 2013-10-01 | PHASE3 |
| NCT06780826 | Shanghai Pulmonary Hospital, Shanghai, China | Lung Cancer, Small Cell | 2024-08-28 | |
| NCT01356680 | University of Cologne | Hodgkin Lymphoma | 2012-01-13 | PHASE3 |
| NCT00379340 | Children´s Oncology Group|National Cancer Institute (NCI) | Stage III Kidney Wilms Tumor|Stage IV Kidney Wilms Tumor | 2007-04-30 | PHASE3 |
| NCT04712903 | AstraZeneca | Small Cell Lung Carcinoma Extensive Disease | 2020-12-16 | PHASE3 |
| NCT03117751 | St. Jude Children´s Research Hospital|Incyte Corporation|Amgen|Servier | Acute Lymphoblastic Leukemia|Acute Lymphoblastic Lymphoma | 2017-03-29 | PHASE2|PHASE3 |
| NCT00002552 | Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) | Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm | 1993-10 | PHASE2 |
| NCT01526603 | Masonic Cancer Center, University of Minnesota | Neuroblastoma | 2012-03-28 | NA |
| NCT00187161 | St. Jude Children´s Research Hospital | Non-Hodgkin Lymphoma|Acute Lymphoblastic Leukemia, Mature B-Cell | 1994-11 | PHASE2 |
| NCT00703820 | St. Jude Children´s Research Hospital|Genzyme, a Sanofi Company|National Cancer Institute (NCI) | Acute Myeloid Leukemia | 2008-08-04 | PHASE3 |
| NCT03182244 | Astellas Pharma Inc | AML With FLT3 Mutation | 2017-10-25 | PHASE3 |
| NCT00869232 | University of Arkansas | Multiple Myeloma | 2008-10 | PHASE2 |
| NCT01035463 | University of Nebraska|National Cancer Institute (NCI) | Anaplastic Large Cell Lymphoma, ALK-Negative|Recurrent Anaplastic Large Cell Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Transformed Non-Hodgkin Lymphoma | 2009-11-12 | PHASE1|PHASE2 |
| NCT01573338 | Bayer | Small Cell Lung Carcinoma | 2013-02-25 | PHASE1|PHASE2 |
| NCT03749018 | David Bond, MD|Bristol-Myers Squibb | Aggressive Non-Hodgkin Lymphoma|Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma|Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma|Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma|Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma|Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma|Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma|Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma|Diffuse Large B-Cell Lymphoma|High Grade B-Cell Lymphoma With MYC and BCL2 and+or BCL6 Rearrangements|High Grade B-Cell Lymphoma, Not Otherwise Specified|Indolent Non-Hodgkin Lymphoma|Mediastinal B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma|Transformed Non-Hodgkin Lymphoma | 2019-01-02 | PHASE2 |
| NCT01439568 | Eli Lilly and Company | Extensive Stage Small Cell Lung Carcinoma | 2011-09 | PHASE2 |
| NCT00042835 | National Cancer Institute (NCI) | Adenocarcinoma of the Lung|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer | 2002-05 | PHASE1 |
| NCT00864318 | Institut Claudius Regaud | Germ Cell Tumors | 2009-03-13 | PHASE2 |
| NCT02661503 | University of Cologne | Classical Hodgkin Lymphoma | 2016-07 | PHASE3 |
| NCT05796089 | Trans Tasman Radiation Oncology Group|AstraZeneca | Extensive-Stage Small-Cell Lung Cancer | 2022-01-01 | PHASE2 |
| NCT01096368 | Children´s Oncology Group|National Cancer Institute (NCI) | Anaplastic Ependymoma|Brain Ependymoma|Cellular Ependymoma|Clear Cell Ependymoma|Ependymoma|Papillary Ependymoma | 2010-05-07 | PHASE3 |
| NCT00005613 | H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI) | Lymphoma | 1996-03 | PHASE2 |
| NCT06236997 | Henan Cancer Hospital|Huazhong University of Science and Technology | Small Cell Lung Carcinoma | 2024-02-10 | PHASE2 |
| NCT00984997 | M.D. Anderson Cancer Center | Lung Cancer | 1993-10 | PHASE2 |
| NCT06372626 | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Neuroendocrine Carcinoma | 2024-05-30 | PHASE1|PHASE2 |
| NCT07061535 | Second Affiliated Hospital, School of Medicine, Zhejiang University|Innovent Biologics, Inc. | Extensive-stage Small Cell Lung Cancer (ES-SCLC)|Extensive Stage Lung Small Cell Cancer|Extensive-Stage Small-Cell Lung Cancer|Extensive Disease Small Cell Lung Cancer | 2025-08-01 | PHASE2 |
| NCT00513474 | Massachusetts General Hospital | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 2008-01 | PHASE1 |
| NCT00238368 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) | Lymphoma | 2004-02 | PHASE2 |
| NCT01857934 | St. Jude Children´s Research Hospital|Cookies for Kids´ Cancer|CURE Childhood Cancer, Inc. | Neuroblastoma | 2013-07-05 | PHASE2 |
| NCT06478264 | Zhangzhou Municipal Hospital | Esophageal Small Cell Carcinoma | 2024-07-13 | PHASE2 |
| NCT01085617 | University College, London | Leukemia|Mucositis|Oral Complications | 2010-12 | |
| NCT00007982 | Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) | Brain and Central Nervous System Tumors|Head and Neck Cancer|Lymphoma | 1999-04 | PHASE2 |
| NCT02337712 | Sun Yat-sen University | Small Cell Lung Cancer | 2015-01 | PHASE2 |
| NCT02483000 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Burkitt Lymphoma|CD20-Positive Neoplastic Cells Present|Diffuse Large B-Cell Lymphoma|Indolent Non-Hodgkin Lymphoma|Mantle Cell Lymphoma|Recurrent B-Cell Non-Hodgkin Lymphoma|Refractory Mature B-Cell Non-Hodgkin Lymphoma | 2017-02-01 | PHASE1 |
| NCT03168594 | Peking University | Neuroendocrine Carcinoma | 2017-04-29 | PHASE2 |
| NCT00265031 | University of Cologne | Hodgkin?s Lymphoma | 1999-01 | PHASE3 |
| NCT05001412 | Zhou Chengzhi|Jiangsu Hengrui Pharmaceutical Co., Ltd. | Extensive Stage Small Cell Lung Cancer | 2021-01-27 | PHASE1 |
| NCT02562365 | Xiaohua Wu MD | Ovarian Cancer | 2015-11 | PHASE2 |
| NCT00202800 | Corewell Health West|Van Andel Research Institute|Eli Lilly and Company|Battle Creek Health System|Mercy Health System|Metropolitan Hospital, Michigan|Mecosta County General Hospital|Munson Medical Center|Saint Mary´s Health Network | Pancreatic Cancer | 2002-03 | PHASE2 |
| NCT00191139 | Eli Lilly and Company | Non-small Cell Lung Cancer | 2003-03 | PHASE2 |
| NCT00186875 | St. Jude Children´s Research Hospital | Acute Lymphoblastic Leukemia|Lymphoma, Lymphoblastic | 2003-11 | PHASE2 |
| NCT00693719 | University of Arizona|National Cancer Institute (NCI) | Breast Cancer | 2007-08 | PHASE2 |
| NCT00876031 | University Hospital Tuebingen|Cooperative Weichteilsarkom Study Group|Deutsche Kinderkrebsstiftung|German Society for Pediatric Oncology and Hematology GPOH gGmbH|Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria|The Swedish Childhood Solid Tumor Working Group|Polish Paediatric Solid Tumours Study Group|Swiss Pediatric Oncology Group | Soft Tissue Sarcoma | 2009-07-01 | PHASE3 |
| NCT07510594 | Tianjin Medical University Cancer Institute and Hospital | Large-Cell Neuroendocrine Carcinoma of the Lung|Extrapulmonary Neuroendocrine Carcinoma | 2026-05-01 | PHASE2 |
| NCT03570983 | Swedish Medical Center | Multiple Myeloma | 2018-09-05 | PHASE2 |
| NCT04870112 | AstraZeneca | Non-Small Cell Lung Cancer|Small Cell Lung Cancer | 2021-06-28 | PHASE1 |
| NCT07296809 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Small Cell Lung Cancer | 2026-01-30 | PHASE2 |
| NCT00003309 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|SWOG Cancer Research Network | Brain and Central Nervous System Tumors | 1999-05-04 | PHASE2 |
| NCT00641381 | City of Hope Medical Center|National Cancer Institute (NCI) | Lymphoma | 2000-05-10 | PHASE1 |
| NCT05091567 | Hoffmann-La Roche|Jazz Pharmaceuticals | Small-Cell Lung Cancer | 2021-11-18 | PHASE3 |
| NCT01141712 | Medical College of Wisconsin|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI)|Blood and Marrow Transplant Clinical Trials Network|National Marrow Donor Program | Lymphoma|HIV | 2010-04 | PHASE2 |
| NCT04383977 | Jiangsu HengRui Medicine Co., Ltd. | Ovarian Cancer | 2020-05 | PHASE2 |
| NCT00002472 | Mayo Clinic|National Cancer Institute (NCI) | Brain and Central Nervous System Tumors|Pediatric Germ Cell Tumor|Extragonadal Germ Cell Tumor | 1991-03 | PHASE2 |
| NCT00004905 | Loyola University|National Cancer Institute (NCI) | Leukemia | 1999-10 | PHASE2 |
| NCT03811002 | National Cancer Institute (NCI)|NRG Oncology | Limited Stage Lung Small Cell Carcinoma|Stage I Lung Cancer AJCC v8|Stage II Lung Cancer AJCC v8|Stage III Lung Cancer AJCC v8 | 2019-07-26 | PHASE3 |
| NCT00002531 | Johann Wolfgang Goethe University Hospital | Leukemia | 1993-01 | PHASE2 |
| NCT04422210 | Hoffmann-La Roche | Small Cell Lung Cancer | 2020-09-22 | PHASE1 |
| NCT03004287 | University of Arkansas|Janssen, LP | Multiple Myeloma | 2017-07-01 | PHASE2 |
| NCT03623087 | The University of Hong Kong | Non-Hodgkin´s Lymphoma, Relapsed|Non-Hodgkin T-cell Lymphoma|Natural Killer+T-Cell Lymphoma, Nasal and Nasal-Type | 2017-07-01 | PHASE3 |
| NCT02858804 | Institute of Hematology & Blood Diseases Hospital, China | Mantle Cell Lymphoma | 2016-01 | PHASE4 |
| NCT04530487 | M.D. Anderson Cancer Center | Desmoplastic Small Round Cell Tumor|Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor|Recurrent Desmoplastic Small Round Cell Tumor|Recurrent Malignant Peripheral Nerve Sheath Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Neuroblastoma|Recurrent Rhabdomyosarcoma|Refractory Desmoplastic Small Round Cell Tumor|Refractory Malignant Peripheral Nerve Sheath Tumor|Refractory Malignant Solid Neoplasm|Refractory Neuroblastoma|Refractory Rhabdomyosarcoma | 2020-08-19 | PHASE2 |
| NCT00135135 | St. Jude Children´s Research Hospital|AstraZeneca|National Institutes of Health (NIH) | Neuroblastoma | 2005-08 | PHASE2 |
| NCT06177925 | Nanfang Hospital, Southern Medical University|Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Respiratory Tract Neoplasms|Thoracic Neoplasms|Neoplasms by Site|Neoplasms|Lung Diseases|Respiratory Tract Diseases|Carcinoma, Bronchogenic|Bronchial Neoplasms|Lung Neoplasms|Small Cell Lung Carcinoma | 2023-12-10 | PHASE2 |
| NCT04322318 | Children´s Oncology Group|National Cancer Institute (NCI) | Anaplastic Kidney Wilms Tumor|Recurrent Kidney Wilms Tumor|Stage II Kidney Wilms Tumor|Stage III Kidney Wilms Tumor|Stage IV Kidney Wilms Tumor | 2020-10-19 | PHASE2 |
| NCT03643276 | Martin Schrappe|Deutsche Krebshilfe e.V., Bonn (Germany) | Acute Lymphoblastic Leukemia, Pediatric | 2018-07-15 | PHASE3 |
| NCT00110110 | The Hospital for Sick Children|Terry Fox Foundation | Retinoblastoma | 2004-06 | PHASE2 |
| NCT02338518 | Jinling Hospital, China | Stomach Neoplasms|Gastric Cancer | 2015-01-04 | PHASE3 |
| NCT00079040 | National Cancer Institute (NCI) | Extensive Stage Small Cell Lung Cancer | 2006-01 | PHASE2 |
| NCT00697671 | St. Jude Children´s Research Hospital|Assisi Foundation | Acute Lymphoblastic Leukemia|Chronic Myelogenous Leukemia|Juvenile Myelomonocytic Leukemia|Myelodysplastic Syndrome|Non-Hodgkin´s Lymphoma | 2007-03 | PHASE1 |
| NCT00003093 | Children´s Oncology Group|National Cancer Institute (NCI) | Neuroblastoma | 1988-03 | PHASE3 |
| NCT02987998 | Nathan Pennell, MD, PhD | Stage IIIA Non-Small Cell Lung Cancer | 2017-05-19 | PHASE1 |
| NCT04924101 | Merck Sharp & Dohme LLC | Small Cell Lung Cancer | 2021-07-15 | PHASE2 |
| NCT06140407 | Vanderbilt-Ingram Cancer Center|Merck Sharp & Dohme LLC | Limited Stage Lung Small Cell Carcinoma|Stage I Lung Cancer|Stage II Lung Cancer|Stage III Lung Cancer | 2024-02-14 | PHASE2 |
| NCT00392834 | AIDS Malignancy Consortium|National Cancer Institute (NCI)|The Emmes Company, LLC | Lymphoma | 2006-09 | PHASE2 |
| NCT02436707 | Canadian Cancer Trials Group|Janssen, LP|Roche Pharma AG|Karyopharm Therapeutics Inc | Lymphoma | 2015-10-27 | PHASE2 |
| NCT02943798 | Shanghai Chest Hospital | Pulmonary Large Cell Neuroendocrine Carcinoma | 2016-12 | PHASE2 |
| NCT00811993 | Hoffmann-La Roche | Neoplasms | 2009-02 | PHASE1 |
| NCT01979536 | National Cancer Institute (NCI) | Anaplastic Large Cell Lymphoma, ALK-Positive|Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma|Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma|Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma | 2013-11-13 | PHASE2 |
| NCT03617432 | Peking University|Peking University International Hospital|Shandong Tumor Hospital|Jiangxi Provincial Cancer Hospital | Experimental Tumor | 2018-08-28 | PHASE2 |
| NCT00372593 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 2006-08 | PHASE3 |
| NCT01055314 | National Cancer Institute (NCI) | Adult Rhabdomyosarcoma|Childhood Alveolar Rhabdomyosarcoma|Childhood Embryonal Rhabdomyosarcoma|Metastatic Childhood Soft Tissue Sarcoma|Stage IV Adult Soft Tissue Sarcoma|Untreated Childhood Rhabdomyosarcoma | 2010-01 | PHASE2 |
| NCT02348216 | Kite, A Gilead Company | Refractory Diffuse Large B Cell Lymphoma (DLBCL)|Relapsed Diffuse Large B-Cell Lymphoma|Transformed Follicular Lymphoma (TFL)|Primary Mediastinal B-cell Lymphoma (PMBCL)|High Grade B-cell Lymphoma (HGBCL) | 2015-04-21 | PHASE1|PHASE2 |
| NCT00275015 | German CLL Study Group | Chronic Lymphocytic Leukemia | 1998-01 | PHASE2 |
| NCT03100955 | Qingdao University | Progression Free Survival | 2017-03-01 | PHASE3 |
| NCT00569985 | City of Hope Medical Center|National Cancer Institute (NCI) | Lymphoma | 2007-06 | PHASE1 |
| NCT00020943 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Lymphoma | 2001-06 | PHASE2 |
| NCT00807755 | University of California, Davis|Novartis | Lung Cancer|Unspecified Adult Solid Tumor, Protocol Specific | 2009-03 | PHASE1 |
| NCT00662233 | Mayo Clinic|National Cancer Institute (NCI) | Ovarian Cancer|Sarcoma | 1991-10 | EARLY_PHASE1 |
| NCT00002876 | Mayo Clinic|National Cancer Institute (NCI) | Brain and Central Nervous System Tumors | 1991-10 | PHASE2 |
| NCT02262325 | Ohio State University Comprehensive Cancer Center | Recurrent Non-small Cell Lung Cancer|Stage IIA Non-small Cell Lung Cancer|Stage IIB Non-small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer | 2015-06-08 | PHASE2 |
| NCT04917250 | Beijing Tongren Hospital | Extranodal NK+T-cell Lymphoma | 2020-03-20 | PHASE2 |
| NCT06564844 | AstraZeneca|Daiichi Sankyo | Non-small Cell Lung Cancer | 2024-10-15 | PHASE3 |
| NCT06480864 | Yunpeng Liu|Jiangsu HengRui Medicine Co., Ltd. | Small Cell Lung Cancer | 2024-08-09 | NA |
| NCT03132532 | Mayo Clinic | Recurrent Lung Non-Small Cell Carcinoma|Stage II Lung Cancer AJCC v8|Stage III Lung Cancer AJCC v8|Unresectable Lung Non-Small Cell Carcinoma | 2017-07-31 | PHASE2 |
| NCT00720447 | Cancer Research UK | Lymphoma | 2008-11 | PHASE2 |
| NCT01722292 | Eli Lilly and Company | Small Cell Lung Carcinoma | 2013-01 | PHASE1|PHASE2 |
| NCT06309732 | Queen Mary University of London | Testicular Neoplasms | 2006-07 | PHASE2 |
| NCT05664971 | Shanghai Junshi Bioscience Co., Ltd. | Advanced Lung Cancer | 2023-02-09 | PHASE1|PHASE2 |
| NCT02658214 | AstraZeneca | Small Cell Lung Carcinoma|Carcinoma, Squamous Cell of Head and Neck|Stomach Neoplasms|Triple Negative Breast Neoplasms|Ovarian Neoplasms|Fallopian Tube Neoplasms|Peritoneal Neoplasms|Esophagogastric Junction Neoplasms|Carcinoma, Pancreatic Ductal|Esophageal Squamous Cell Carcinoma | 2016-04-28 | PHASE1 |
| NCT04005716 | BeiGene | Small Cell Lung Cancer | 2019-07-22 | PHASE3 |
| NCT04189952 | University of Miami|AstraZeneca | Diffuse Large B Cell Lymphoma|Chronic Lymphocytic Leukemia|Small Lymphocytic Leukemia|Marginal Zone Lymphoma | 2020-09-22 | PHASE2 |
| NCT00006455 | Gustave Roussy, Cancer Campus, Grand Paris | Lymphoma | 1999-11-26 | PHASE3 |
| NCT06536868 | Second Hospital of Shanxi Medical University | Extensive-stage Small-cell Lung Cancer | 2024-08-01 | PHASE2 |
| NCT00869752 | NCIC Clinical Trials Group|Merck Frosst Canada Ltd. | Lung Cancer | 2009-12-16 | PHASE1|PHASE2 |
| NCT06857747 | QIAO LI | Breast Cancer | 2025-03-01 | NA |
| NCT04028050 | Hoffmann-La Roche | Small Cell Lung Carcinoma | 2019-08-12 | PHASE3 |
| NCT04363255 | Taizhou Hospital | Small Cell Lung Carcinoma | 2020-05-01 | PHASE2 |
| NCT00776698 | Hoffmann-La Roche | Non-Squamous Non-Small Cell Lung Cancer | 2009-04 | PHASE1 |
| NCT01710176 | Italian Sarcoma Group|French Sarcoma Group|Grupo Espanol de Investigacion en Sarcomas | Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults | 2011-06-01 | PHASE3 |
| NCT00360750 | Children´s Cancer and Leukaemia Group | Retinoblastoma | 2005-09 | NA |
| NCT00079482 | Cephalon | Acute Myeloid Leukemia | 2003-10 | PHASE2 |
| NCT00002524 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Lymphoma | 1993-06 | PHASE2 |
| NCT03458260 | The Lymphoma Academic Research Organisation | Aggressive Non-Hodgkin Lymphoma | 2018-12-26 | PHASE2 |
| NCT02499770 | G1 Therapeutics, Inc. | Small Cell Lung Cancer | 2015-06-26 | PHASE1|PHASE2 |
| NCT00080886 | University of Nebraska|National Cancer Institute (NCI) | Lymphoma | 2002-05-08 | PHASE2 |
| NCT00004903 | Robert H. Lurie Cancer Center|National Cancer Institute (NCI) | Multiple Myeloma and Plasma Cell Neoplasm | 1999-10 | PHASE2 |
| NCT00574080 | University of Arkansas | Multiple Myeloma | 2006-07 | PHASE3 |
| NCT00576979 | City of Hope Medical Center|National Cancer Institute (NCI) | Leukemia | 2008-03-04 | PHASE1|PHASE2 |
| NCT03840902 | EMD Serono Research & Development Institute, Inc.|Merck KGaA, Darmstadt, Germany | Non-small Cell Lung Cancer | 2019-04-16 | PHASE2 |
| NCT07141264 | Tang-Du Hospital | SCLC,Extensive Stage | 2025-08-25 | PHASE2 |
| NCT00002567 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Bone Marrow Ablation|Leukemia | 1994-03 | PHASE2 |
| NCT03850067 | Celgene | Small Cell Lung Carcinoma | 2019-03-12 | PHASE1 |
| NCT05711628 | National Cancer Institute (NCI) | Recurrent Classic Hodgkin Lymphoma|Refractory Classic Hodgkin Lymphoma | 2023-08-10 | PHASE3 |
| NCT01563601 | Cephalon | Extensive-stage Small Cell Lung Cancer | 2012-08 | PHASE3 |
| NCT00003696 | Commissie Voor Klinisch Toegepast Onderzoek | Lung Cancer | 1998-10 | PHASE3 |
| NCT00002478 | Gynecologic Oncology Group|National Cancer Institute (NCI) | Cervical Cancer|Ovarian Cancer | 1993-06 | PHASE2 |
| NCT00514540 | M.D. Anderson Cancer Center | Prostate Cancer | 2006-05 | PHASE2 |
| NCT05008224 | Merck Sharp & Dohme LLC | Classical Hodgkin Lymphoma | 2021-10-07 | PHASE2 |
| NCT00002532 | Hannover Medical School | Leukemia | 1993-01 | PHASE2 |
| NCT00006734 | Children´s Oncology Group|National Cancer Institute (NCI)|SWOG Cancer Research Network | Sarcoma | 2001-05 | PHASE3 |
| NCT06393816 | Centre Leon Berard|Groupe Francais De Pneumo-Cancerologie | Large Cell Neuroendocrine Carcinoma of the Lung | 2024-06-13 | PHASE2 |
| NCT00003114 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) | Lymphoma | 1997-07 | PHASE2 |
| NCT00070187 | Children´s Oncology Group|National Cancer Institute (NCI) | Lymphoma | 2003-11 | PHASE2|PHASE3 |
| NCT06485544 | Tang-Du Hospital | Small Cell Lung Cancer (SCLC) | 2024-07-01 | PHASE2 |
| NCT01180322 | University of Ulm | Acute Myeloid Leukemia (AML) | 2010-11 | PHASE2 |
| NCT00534430 | City of Hope Medical Center|National Cancer Institute (NCI) | Leukemia|Myelodysplastic Syndromes | 2000-02-29 | PHASE2 |
| NCT00005867 | Lymphoma Trials Office | Lymphoma | 1998-01 | PHASE3 |
| NCT00345865 | Masonic Cancer Center, University of Minnesota | Lymphoma | 2005-08-24 | PHASE2 |
| NCT00004010 | Children´s Oncology Group|National Cancer Institute (NCI) | Lymphoma | 1999-10 | PHASE2 |
| NCT03517137 | European Organisation for Research and Treatment of Cancer - EORTC | Advanced Hodgkin Lymphoma | 2019-08-01 | PHASE2 |
| NCT03117010 | Samsung Medical Center | Hemophagocytic Lymphohistiocytoses | 2017-01-01 | |
| NCT05903092 | Hirva Mamdani|AstraZeneca|Barbara Ann Karmanos Cancer Institute | Small Cell Lung Cancer|SCLC|Extensive Stage Small Cell Lung Cancer|Limited Stage Small-Cell Lung Cancer | 2023-09-26 | PHASE2 |
| NCT00199147 | Johann Wolfgang Goethe University Hospital | Acute Myeloid Leukemia | 2000-01 | PHASE4 |
| NCT04683198 | Chinese Academy of Medical Sciences | Small-cell Lung Cancer | 2021-04-01 | PHASE2 |
| NCT04947501 | Memorial Sloan Kettering Cancer Center | Neuroblastoma|Pediatric Cancer | 2021-06-22 | EARLY_PHASE1 |
| NCT00005863 | Medical Research Council | Leukemia|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 1998-08 | PHASE3 |
| NCT03509012 | AstraZeneca | Carcinoma, Squamous Cell of Head and Neck|Carcinoma, Non-Small-Cell Lung|Small Cell Lung Carcinoma | 2018-05-02 | PHASE1 |
| NCT04038411 | Mingzhi Zhang | NK+T Cell Lymphoma | 2019-04-01 | PHASE4 |
| NCT01921387 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Recurrent B-Cell Non-Hodgkin Lymphoma|Recurrent Hodgkin Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent T-Cell Non-Hodgkin Lymphoma|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Hodgkin Lymphoma|Refractory Mantle Cell Lymphoma|Refractory T-Cell Non-Hodgkin Lymphoma | 2013-10-09 | PHASE1|PHASE2 |
| NCT00003812 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Lung Cancer | 1999-03 | PHASE2 |
| NCT00027898 | National Cancer Institute (NCI) | Unspecified Adult Solid Tumor, Protocol Specific | 2002-01 | PHASE1 |
| NCT05774028 | The First Affiliated Hospital with Nanjing Medical University | NK-T-Cell Lymphoma, Extranodal | 2023-04 | PHASE2 |
| NCT06771622 | FBD Biologics Limited | Solid Cancer | 2025-03-13 | PHASE1|PHASE2 |
| NCT06157827 | Nanjing Leads Biolabs Co.,Ltd | Advanced Neuroendocrine Carcinoma | 2023-12-08 | PHASE1|PHASE2 |
| NCT00002854 | City of Hope Medical Center|National Cancer Institute (NCI) | Cancer | 1994-12 | PHASE1 |
| NCT00002941 | Children´s Oncology Group|National Cancer Institute (NCI) | Lymphoma | 1998-04 | PHASE2 |
| NCT02631239 | Ruijin Hospital | Extranodal NK+T-cell Lymphoma, Nasal Type | 2016-03-16 | PHASE3 |
| NCT01849783 | Margarida Magalhaes-Silverman|National Cancer Institute (NCI) | Extramedullary Plasmacytoma|Isolated Plasmacytoma of Bone|Light Chain Deposition Disease|Primary Systemic Amyloidosis|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma | 2013-04-04 | PHASE2 |
| NCT04562337 | Shandong Cancer Hospital and Institute | Extensive-stage Small Cell Lung Cancer | 2020-10-01 | PHASE2 |
| NCT03781869 | Third Military Medical University | Extensive-stage Small Cell Lung Cancer | 2018-12 | PHASE2 |
| NCT02848183 | Samsung Medical Center | Pediatric Acute Myeloid Leukemia | 2016-01 | PHASE2 |
| NCT01281696 | National Taiwan University Hospital|Taipei Veterans General Hospital, Taiwan|Taichung Veterans General Hospital|Chang Gung Memorial Hospital | Breast Neoplasms|Leptomeningeal Metastasis|Brain Metastases | 2011-01 | PHASE2 |
| NCT00556127 | Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie | Diffuse Large B-Cell Lymphoma|POOR PROGNOSIS | 2002-06 | PHASE2 |
| NCT04047862 | BeiGene | Locally Advanced and Metastatic Solid Tumors | 2019-08-15 | PHASE1 |
| NCT00101205 | National Cancer Institute (NCI) | Angioimmunoblastic T-cell Lymphoma|B-cell Childhood Acute Lymphoblastic Leukemia|B-cell Chronic Lymphocytic Leukemia|Childhood Burkitt Lymphoma|Childhood Diffuse Large Cell Lymphoma|Childhood Grade III Lymphomatoid Granulomatosis|Childhood Immunoblastic Large Cell Lymphoma|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent+Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Small Intestine Lymphoma|T-cell Childhood Acute Lymphoblastic Leukemia|T-cell Large Granular Lymphocyte Leukemia|Unspecified Childhood Solid Tumor, Protocol Specific | 2004-11 | PHASE1 |
| NCT00000660 | National Institute of Allergy and Infectious Diseases (NIAID)|Bristol-Myers Squibb | Sarcoma, Kaposi|HIV Infections | | PHASE1 |
| NCT06132113 | Boehringer Ingelheim | Neuroendocrine Neoplasms | 2024-01-22 | PHASE1 |
| NCT00007813 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Amgen|Baxter Healthcare Corporation|Nexell Therapeutics Inc | Brain and Central Nervous System Tumors|Childhood Germ Cell Tumor|Extragonadal Germ Cell Tumor|Liver Cancer|Neuroblastoma|Ovarian Cancer|Sarcoma|Testicular Germ Cell Tumor | 1997-05-31 | PHASE1 |
| NCT00006056 | Fairview University Medical Center | Chediak-Higashi Syndrome|Graft Versus Host Disease|X-Linked Lymphoproliferative Syndrome|Familial Erythrophagocytic Lymphohistiocytosis|Hemophagocytic Lymphohistiocytosis|Virus-Associated Hemophagocytic Syndrome | 2000-03 | NA |
| NCT03161054 | Fondazione Italiana Linfomi - ETS | Aggressive Non-Hodgkin Lymphoma | 2017-09-12 | PHASE2 |
| NCT05298423 | Merck Sharp & Dohme LLC | Carcinoma, Non-Small-Cell Lung | 2022-05-03 | PHASE3 |
| NCT00544596 | National Cancer Institute (NCI) | Extensive Stage Small Cell Lung Cancer|Unspecified Adult Solid Tumor, Protocol Specific | 2007-09 | PHASE1 |
| NCT03579927 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | CD19 Positive|Mantle Cell Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Follicular Lymphoma|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Refractory Follicular Lymphoma | 2019-10-03 | PHASE1|PHASE2 |
| NCT01840566 | Memorial Sloan Kettering Cancer Center | Non-Hodgkin´s Lymphoma | 2013-04 | PHASE1 |
| NCT00005022 | Radiation Therapy Oncology Group|National Cancer Institute (NCI) | Lung Cancer | 1998-02 | PHASE1 |
| NCT00242996 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) | Lymphoma | 2004-03 | PHASE2 |
| NCT00554788 | Children´s Oncology Group|National Cancer Institute (NCI) | Extraocular Retinoblastoma | 2008-05-06 | PHASE3 |
| NCT07498959 | Sahlgrenska University Hospital|Karolinska University Hospital|Haukeland University Hospital|University Hospital of North Norway|Oslo University Hospital|Trondheim University Hospital|Uppsala University Hospital|University Hospital, Ume?|Lund University Hospital | Testicular Cancer|Seminoma|Quality of Life|De-escalation|RPLND | 2026-03-19 | NA |
| NCT06911606 | Guangdong Provincial People´s Hospital|Liaoning Cancer Hospital & Institute|Guangzhou No.12 People´s Hospital|Second Xiangya Hospital of Central South University | SCLC, Limited Stage | 2024-05-22 | PHASE2 |
| NCT00568464 | Fudan University | Ewing´s Sarcoma | 2007-03 | PHASE2 |
| NCT00199056 | Goethe University | Adult Acute Lymphocytic Leukemia | 1999-10 | PHASE4 |
| NCT00250094 | New Mexico Cancer Research Alliance | Ovarian Cancer | 2004-05 | PHASE1 |
| NCT05955170 | Institut Curie|Seagen Inc. | HER2-positive Breast Cancer | 2023-12-19 | PHASE2 |
| NCT05665114 | Zhejiang University|Hangzhou Qihan Biotech Co., Ltd. | AML, Adult | 2022-12-24 | PHASE1 |
| NCT05576181 | Fundamenta Therapeutics, Ltd.|The First Affiliated Hospital of Zhengzhou University | Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited | 2022-10-15 | PHASE1 |
| NCT00199017 | Johann Wolfgang Goethe University Hospital | Lymphoma, Lymphoblastic | 2004-04 | PHASE4 |
| NCT05422183 | Zhongda Hospital | Ovarian Cancer, Epithelial | 2022-06-30 | PHASE2 |
| NCT00199004 | Johann Wolfgang Goethe University Hospital | Adult Acute Lymphocytic Leukemia | 2004-04 | PHASE4 |
| NCT00199082 | Nicola Goekbuget | Burkitt´s Lymphoma|Burkitt´s Leukemia|Mediastinal Neoplasms|Lymphoblastic Lymphoma|Large Cell Anaplastic Lymphoma | 2002-07 | PHASE4 |
| NCT01949129 | St. Anna Kinderkrebsforschung|ALL SCTped Forum|European Society for Blood and Marrow Transplantation|ALL-BFM Study Group|Assistance Publique - H?pitaux de Paris|Dutch Childhood Oncology Group|Swiss Pediatric Oncology Group|Australian & New Zealand Children´s Haematology+Oncology Group | Acute Lymphoblastic Leukaemia | 2013-04 | PHASE2|PHASE3 |
| NCT02036489 | PETHEMA Foundation | Acute Lymphobkastic Leukemia | 2008-01 | PHASE4 |
| NCT02881086 | Goethe University | Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma | 2016-08 | PHASE3 |
| NCT01702961 | Baylor College of Medicine|The Methodist Hospital Research Institute|Center for Cell and Gene Therapy, Baylor College of Medicine | Lymphoma|Hodgkin´s Disease | 2002-06 | NA |
| NCT00568607 | Fudan University | Lymphoma | 2007-03 | PHASE2 |
| NCT02866136 | Institut Curie|Fondation Rothschild Paris | Retinoblastoma|Children|Retinal Neoplasm | 2012-02 | PHASE2 |
| NCT01385891 | Istituto Giannina Gaslini | Acute Leukemia | 2008-08 | PHASE2|PHASE3 |
| NCT01538472 | M.D. Anderson Cancer Center|Biogen | Lymphoma | 2003-09 | PHASE1|PHASE2 |